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Abstract

CHARACTERIZATION OF POTENTIAL INTERACTIONS BETWEEN TRANSFERRIN
BINDING PROTEINS IN NEISSERIA GONORRHOEAE

By Shreni Dilipkumar Mistry

A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University

Virginia Commonwealth University, 2013

Major Director: Cynthia Nau Cornelissen, Ph.D.
Professor of Microbiology and Immunology

Neisseria gonorrhoeae requires iron for survival and establishment of infection in the
human host. Pathogenic Neisseriae have evolved a repertoire of high-affinity iron acquisition
systems to facilitate iron uptake in the human host. This requires specific outer membrane
receptors and energy-harnessing cytoplasmic membrane proteins. The transferrin receptor
proteins of Neisseria gonorrhoeae are necessary for iron uptake from transferrin in the host. The
iron uptake system consists of two transferrin binding proteins, (Tbp) A and B. TbpA is an
xv

integral outer membrane, TonB-dependent transporter that forms the pore for iron
internalization. TbpB is a surface exposed lipoprotein that makes the iron internalization process
more efficient.
TbpA is proposed to consist of two distinct domains: a β barrel and an N-terminal plug
domain. Previous studies have shown that the EIEYE sequence in the TbpA plug domain plays
an important role in iron internalization. We undertook a collaborative project to test the
hypothesis that the conserved EIEYE sequence in the wild-type TbpA plug binds Fe3+ during the
outer membrane iron transport process. CD spectra analysis and fluorescence emission titration
spectra of purified recombinant wildtype and mutated plug proteins revealed that Fe3+ is
sequestered by the wildtype TbpA plug protein, unlike the mutated plug protein. Modeling data
with the wild-type plug predicts the EIEYE sequence is part of a flexible loop structure and acts
as an Fe3+ binding site.
Characterization of the Tbps constituting the gonococcal receptor is important to
understanding how the gonococcus survives within its host. TbpA and TbpB act together to
acquire iron from human transferrin. We hypothesize that the presence of TbpA impacts the
exposure or conformation of TbpB. In this study, we have utilized photoactivable cross-linkers to
assess the effect of TbpA on TbpB in live gonococcal cells and studied it in presence of ligand
and TonB derived energy. We employed insertion mutants, in which TbpA and TbpB contained
the hemagglutinin (HA) epitope tag, to probe for impact of TbpA on TbpB. Our results
demonstrate that photo-cross-linking altered TbpB size and migration and was dependent on the
presence of TbpA. HA epitope insertion mutants in surface exposed loops of TbpA and TbpB did
not impact the mobility of cross-linked TbpB. Addition of human transferrin to the de-energized
xvi

mutant caused a change in TbpB migration after cross-linking. This result indicates that when
ligand is bound tightly and irreversibly to de-energized TbpA, the surface accessibility and
perhaps conformation of TbpB is altered and TbpA does not interact with TbpB. Our findings
were confirmed with recent structural studies of TbpA-TbpB-ligand triple complex, which
illustrate that Tbps bind ligand through unique, non-overlapping binding sites such that TbpA
and TbpB do not interact.
TbpB is not an essential member of transferrin-iron acquisition pathway. It is surface
exposed and tethered to the outer membrane by a lipid moiety. The role of TbpB has not been
clearly outlined in the transferrin iron acquisition system. The last objective of this study was to
look at the significance of two specific conserved regions of TbpB and its importance in
transferrin iron utilization and TbpA-TbpB interaction. Using site-directed mutagenesis we
created two mutants, in the first mutant the conserved lipobox of TbpB was replaced with a
signal I peptidase cleavage site, and the second mutant contained a deletion of the conserved
poly glycine residue stretch, immediately downstream of the lipobox. Our results indicate that
lipobox is required for lipidation of TbpB, both the mutants were impaired for transferrin-iron
utilization, and neither of the mutations altered TbpA-TbpB interaction.
Overall, these studies help elucidate the functional importance of the specific regions in
TbpA and TbpB in Neisseria gonorrhoeae, thereby adding to our understanding of the process of
iron acquisition through the transferrin binding proteins.

xvii

CHAPTER 1: INTRODUCTION

I. The family Neisseriaceae
Historically, the family Neisseriaceae is comprised of four genera Neisseria,
Moraxella, Kingella, and Acinetobacter (21, 101, 219, 220). These four genera are
classified as Gram-negative and differentiated from each other based on cell
morphology, presence of oxidase, catalase, thymidine kinase, carbonic anhydrase,
acid production from glucose, and nitrite reduction (Table 1). The microorganisms
included in these four genera are medically significant to humans as pathogens and or
commensals.

II. The Genus Neisseria
Albert Neisser discovered Neisseria gonorrhoeae in 1897 (219) and the genus
Neisseria was named after him (219). Following this discovery, N. meningitidis was
isolated by Weischelbaum in 1887, N. sicca, N. mucosa, and N. subflava were
isolated by Ligenlsheim in 1906, and N. flavescens was discovered by Branhman in
1930 (219).
The Neisseria species are Gram-negative, non-motile, non-spore forming cocci,
found in pairs. Depending on the species, age of cultures, and source of the isolate,
individual cells of Neisseria may range from 0.6 to 1.5 µm in size. These are
fastidious microorganisms, requiring complex growth media. They are aerobic or
facultative aerobic and grow best between 35-37oC in a humidified atmosphere of 510% CO2. Neisseria species are differentiated on the biochemical basis of production
1

Table 1. Characteristics of the genera included in the Family Neisseriaceae

Characteristics

Genus
Neisseria

Kingella

Moraxella

Acinetobacter

Diplococci*

Cocobacilli

Rods

Rods

Oxidase

+

+

+

-

Catalase

+

-

+

-

Acid production from
Glucose

+

+

-

+/-

Nitrite reduction

+

+

-

-

Cell Morphology

*exception is N. elongata, it is rod-shaped
This table has been adapted from CDC (38)
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of acid from carbohydrates and nitrite reduction. This genus includes species that are
commensals or human pathogens, as illustrated in Table 2. Most of these Neisseria
species are found in the mucous membranes of the respiratory and urogenital tracts.
The Neisseria species can be divided into two broad groups; the pathogenic and
the non-pathogenic. The two important human pathogens are Neisseria gonorrhoeae
and Neisseria meningitidis. These two pathogens are closely related genetically (209),
despite expressing some of the same virulence factors, the diseases caused by them
are different. Neisseria meningitidis is the causative agent of bacterial meningitis and
severe sepsis, and Neisseria gonorrhoeae is the principle agent of the sexually
transmitted infection, gonorrhea.

III. Diseases caused by Neisseria species

A. Meningococcal Disease- Infection and Epidemiology
Meningococcal disease can occur as epidemic or endemic cases. N.
meningitidis serogroup A has caused major epidemics of meningitis in Africa with
periodic epidemics occurring in the Sub-Saharan African region, especially in the
'meningitis belt' (200). Neisseria meningitidis is a common commensal, isolated
from the nasopharynx of 8–20% of healthy individuals (92, 200). The duration of
carriage is variable (approximately 4 months), with differences being observed
between different N. meningitidis serogroups (108). The carriage strains are more
widespread in nature than disease-causing strains and N. meningitidis is an occasional
pathogen, as sometimes during the bacteria-host interaction meningococcal disease is
3

Table 2: Characteristics of Human-Associated Neisseria Species
Acid production from
Species

Polysaccharide from
Glucose

Reduction of
Nitrate

Association with
Humans

Glucose

Maltose

Sucrose

Fructose

Lactose

N. gonorrhoeae

Y

N

N

N

N

N

N

Pathogen

N. meningitidis

Y

Y

N

N

N

N

N

I

N. lactamica

Y

Y

N

N

Y

N

N

Commensal

N. cinerea

N

N

N

N

N

N

N

Commensal

N. polysaccharea

Y

Y

N

N

N

Y

N

Commensal

N. subflava

Y

Y

N

N

N

N

N

Commensal

N. sicca

Y

Y

Y

Y

N

Y

N

Commensal

N. mucosa

Y

Y

Y

Y

N

Y

Y

Commensal

N. flavescens

N

N

N

N

N

Y

N

II

N. elongata

N

N

N

N

N

N

N

Commensal

I) N. meningitidis occurs in carrier state, with some serogroups causing epidemics/pandemics
II) N. flavescens was isolated from an outbreak of meningitis. There have been no reliable descriptions of isolation of this species, apart from the original
description.
Table adapted from CDC (38)
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an accidental outcome (208). Meningococcal disease incidence varies in human
populations from rare to over 1000/100,000 population/year. Meningococcal disease
occurs as sporadic cases, localized outbreaks and case clusters, and epidemic and
pandemic disease (144).
Structural differences in capsular polysaccharide, lipo-oligoscaachride and outer
membrane proteins help in characterizing and classifying the meningococci into
different serogroups and serotypes. There are 13 diverse polysaccharide capsules but
only A, B, C, W-135, and Y commonly cause invasive infections (78). The highest
incidence of meningococcal disease occurs in the meningitis belt of sub-Saharan
Africa. During epidemics, the incidence can approach 1000 cases per 100,000
population, or 1% of the population. Serogroup A has been the most important
serogroup in this region. However, serogroup C and X mediated disease has also
occurred (76, 78, 233).
In the Americas, the reported incidence of disease is in the range of 0.3-4 cases
per 100,000 population, which is much lower than in the meningitis belt. The bulk of
the disease in the Americas is caused by serogroups C and B, although serogroup Y
causes a substantial proportion of infections in some countries and W-135 is
becoming increasingly problematic as well (26, 40). The majority of meningococcal
disease in European countries, which ranges in incidence from 0.2 to 14 cases per
100,000, is caused by serogroup B strains (201).
N. meningitidis is a frequent asymptomatic colonizer of the human upper
respiratory tract, and is carried in the nasopharynx by 5-15% of healthy adults and
5

children and it may be acquired through the inhalation of respiratory droplets (26, 35,
213). The organism establishes intimate contact with non-ciliated mucosal epithelial
cells of the upper respiratory tract, where it may enter the cells briefly before
migrating back to the apical surfaces of the cells for transmission to a new host.
In susceptible individuals, once in the blood, N. meningitidis may survive,
multiply rapidly and disseminate throughout the body and into the CSF (26, 146).
Meningitis occurs when bacteria interact with the endothelial cells of the brain
microvessels and cross the blood-brain barrier. Symptoms develop within 1–14 days
of acquisition and include fever, nausea, headache, purpura, petechiae, photophobia,
stiff neck, and change in mental status (221). Less common manifestations of
meningococcal disease include septic arthritis, pneumonia, purulent pericarditis and
conjunctivitis, among others (33, 202). Serious infections are usually manifested as
meningitis and septicaemia (33, 237) Meningococcal sepsis, which is also called
meningococcemia, occurs in only 5 to 20 percent of patients. Meningococcemia is
characterized by an abrupt onset of fever and purpuric rash. (179). The overall case
fatality rates over the past 20 years have been at 9 to 12 percent, with a rate of up to
40 percent among patients with meningococcal sepsis. Eleven to 19 percent of
survivors sustain permanent sequelae including deafness and mental retardation
(179).
The outcomes of meningococcal infection may be devastating and, in the absence
of timely intervention, can lead to neurological disorders and death. For management
of the disease the recommended treatment includes administration of antibiotics like
penicillin or ceftriaxone (35, 179). Due to the high rates of morbidity and mortality
6

associated with meningococcal disease and increasing antibiotic resistance, for
prevention control, two vaccines are available in the United States. They are (i)
MCV4-a meningococcal conjugate vaccine, where cell surface polysaccharides from
serogroups A, C, Y and W-135 are conjugated to diphtheria toxoid; and (ii) MPSV4a meningococcal polysaccharide vaccine against serogroups A, C, Y, and W-135
(26). The ultimate control of meningococcal disease requires widespread surveillance,
the expanded use of polysaccharide conjugate vaccines, and the development of
broadly effective serogroup B vaccines to prevent this microorganism from posing as
a major threat to human health in industrialized countries.

B. Gonococcal Disease- Infection and Epidemiology
Gonorrhoea is a global health concern and cause of serious reproductive
complications in women. After chlamydia, gonorrhea is the second most commonly
reported notifiable disease in the United States (36, 37). In 2011, a total of 321,849
cases of gonorrhea were reported in the United States, yielding a rate of 104.2 cases
per 100,000 population, increasing the rate by 4.0% since 2010 (36). In reality these
numbers are thought to be under-represented due to under-reporting and
asymptomatic infection. In 2011, persons aged 15–44 years accounted for 94.6% of
reported gonorrhea cases, with the highest rates observed among women and men
aged 20-24 years. Gonorrhea rates were higher in women than in men and the African
American community showed gonorrhea infection rates that were 4-5 times the
national average with a rate of 427.3 cases per 100,000 population (33, 36).

7

N. gonorrhoeae is the causative agent of the sexually transmitted infection
gonorrhoea. N. gonorrhoeae is transmitted through close sexual contact with infected
individuals, and vertical transmission occurs when the gonococcal infection is passed
from mother to her newborn during childbirth. N. gonorrhoeae primarily infects the
urethral epithelium in males (2, 46) and the ectocervial and endocervical epithelium
in females (65). Secondary infections can occur in the rectum, conjunctiva and the
pharynx (66). In men, symptoms typically begin 2-5 days after infection,
characterized by purulent urethral discharge and dysuria. Secondary infections occur
as bacteria ascend the upper genital tract to cause epididymitis, prostatitis, and
urethritis. Approximately 10 days after infection, women infected with N.
gonorrhoeae, experience cervicitis/urethritis, causing increased vaginal discharge,
dysuria and menstrual abnormalities. (17, 87, 102, 196). It is estimated that as many
as 80% of infected females are asymptomatic (197). This makes diagnosis difficult
and leads to almost half of the infected females developing ascending gonococcal
infections. If left untreated this can lead to serious downstream sequelae such as
pelvic inflammatory disease (PID), resulting in scarring of the fallopian tubes, ectopic
pregnancies, and infertility (149, 207). It is estimated that 10% of women suffer from
PID (3, 66). Dissemination of the gonococci into the bloodstream results in
disseminated gonococcal infection (DGI), though it is less common and occurs in 0.53% of infected individuals. DGI can cause arthritis-dermatitis syndrome, endocarditis,
sepsis or meningitis in rare cases (66, 174, 197).
Gonorrhea treatment has been complicated by the ability of N. gonorrhoeae to
develop resistance to antimicrobials used for treatment. Gonorrhea has progressively
8

developed resistance to the antibiotic drugs prescribed to treat it. In the past
gonorrhoea was treatable with single-dose treatment with penicillin or streptomycin;
however by 1958 resistance had been reported (156). By 1986, the CDC reported that
over 22% of all isolates collected by gonococcal isolate surveillance project (GISP)
were resistant to tetracycline and or penicillin (103). In 1993, fluoroquinolones and
cephalosporins (ceftriaxone and cefixime) were the recommended treatments for
gonorrhea. In the early 2000s ciprofloxacin resistance was detected among men who
have sex with men (MSM) with gonorrhea. By 2006, 13.8% of isolates exhibited
resistance to ciprofloxacin. On April 13, 2007, CDC stopped recommending
fluoroquinolones as treatment for gonococcal infections for all persons in the United
States (33, 34, 36). In 2011, 30.4% of isolates collected in GISP were resistant to
penicillin, tetracycline, ciprofloxacin, or a combination of these antimicrobials. The
effectiveness of cefixime for treating gonorrhea is declining, which has made CDC
update its gonorrhea treatment guidelines. CDC no longer recommends the routine
use of cefixime. CDC now recommends using ceftriaxone to treat gonorrhea (61).
The first known failure of ceftriaxone and cefixime to successfully treat a case of
gonorrhea reportedly occurred in Japan in 2003.The World Health Organization
recently reported that a major public health crisis emerging, in the form of gonorrhea
that doesn't respond to antibiotics. In 2009, the so-called gonorrhea "superbug" was
found in Japan as well. It has been subsequently found at least once
in Spain and France, but not yet in the U.S. (147, 214). Another cause for concern is
the observation that gonococcal infection leads to increased transmission of the
human immunodeficiency virus (HIV) (57, 72, 110). HIV transmission increases due
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to the stimulation of viral HIV-LTR-dependent transcription by exposure to Neisseria
gonorrhoeae (41). It has also been reported that in HIV infected individuals,
concomitant infection with gonococci, leads to increased HIV shedding in genital
secretions (45). These findings coupled with major rise in antibiotic resistance among
Neisseria gonorrhoeae isolates make it critical to continuously monitor antibiotic
resistance in Neisseria gonorrhoeae and encourage research, development and
identification of alternative effective treatment regimens for gonococcal infections.
IV. Gonococcal Virulence Factors
For successful survival in the human host, gonococci express several cellular
surface proteins that help in colonization and evasion of the host immune response.
These surface proteins or virulence factors are subject to high frequency phase or
antigenic variation, such that it offers several benefits to the bacterium. These
virulence factors are discussed, to gain a greater understanding of the contribution of
these virulence factors to successful gonococcal pathogenesis. A repertoire of
virulence factors has been identified, which allow this bacterium to successfully adapt
to variable microenvironments within its human host. This human adaptability and
the repeated phase and antigenic change displayed by the gonococcus have hampered
vaccine development. Many of the major virulence factors undergo phase and/or
antigenic variation.
A. Porin
Porins are virulence proteins present in the outer membrane of the
pathogenic Neisseria species, and are characterized by a trimeric β-barrel
structure. Neisserial porins function by forming aqueous transmembrane
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channels and they modulate the exchange of ions between the bacteria and the
surrounding environment (66, 124). N. meningitidis expresses two types of
porins, PorA and PorB. N. gonorrhoeae expresses only a PorB homolog; this
is classified into two serotypes termed PIA and PIB (83). Gonococcal PorB is
not subject to high frequency phase or antigenic variation (198), whereas
meningococcal PorA is phase variable (216).
Gonococcal porin can associate with G-actin, affect the kinetics of actin
filament formation, and cause remodeling of preformed actin filaments,
suggesting a role for this protein in the rearrangement of the actin
cytoskeleton that occurs during the early stages of the infective process (228).
It has been reported that gonococcal PorB has the ability to translocate into
the eukaryotic cell membranes and form voltage-gated channels (modulated
by ATP and GTP); this promotes invasion of host cells (14, 66, 118, 226).
The neutrophil expression of immunoglobulin G (IgG) Fc receptors II and III,
as well as the activation-dependent down regulation of Fc gamma RIII, were
reduced by the meningococcal and gonococcal porins; they also inhibited the
phagocytic capacity of neutrophils (12, 139).
Gonococcal porins play an important role in enabling the bacteria to evade
complement-mediated killing. The gonococcal porin PorB1A is critical in
modulating stable serum resistance, which is not mediated by
lipooligosaccharide (LOS) sialylation. Binding of factor H to PorB1A
downregulates the alternative pathway of complement (124). It has been
demonstrated that the N. gonorrhoeae porin PorB1B interacts with
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mitochondria of HeLa cells and induces calcium efflux and caspase activity
along with apoptosis (141, 142).

B. Lipooligosaccharide (LOS)
Most Gram-negative bacteria possess lipopolysaccharide (LPS) on their
outer membrane. LPS of pathogenic Neisseria strains is comprised of a lipid
A moiety, which anchors the molecule in the outer membrane, and a relatively
short variable polysaccharide unit that lacks the repeating 0-antigens that are
characteristic of the LPS of Gram-negative enteric bacteria (121, 218). The
LOS undergoes high frequency antigenic variation. Glycosyl transferases add
sugar residues to the core polysaccharide during LOS synthesis. These
transferases contain poly G tracts within their genes, which enables them to
undergo slip-strand mispairing, and resulting in the turning on or off of these
genes. Altering the expression of these transferases leads to changes in LOS
size and structure, due to variations in carbohydrate composition (27, 38, 58,
66, 90). LOS can also be modified using host derived cytidine 5’-monophospho-N-acetyleneuraminic acid (CMP-NANA) found in human sera and
secretions. CMP-NANA is used as the sialyl donor and membrane bound
sialyltransferase mediate the process (121, 122).
Neisseria are able to exhibit molecular mimicry through LOS, as they
evade recognition as foreign by the host cells and affect cell function or even
gain access to the cell interior (121). LOS sialylation makes it bind factor H,
allowing the gonococcus to acquire serum resistance since complement
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mediated killing via the alternate pathway is inhibited (167). Phase variation
of LOS controls both bacterial entry into human mucosal cells, and bacterial
susceptibility to killing by antibodies and complement (217). This reversible
switch between cell-evasive to an immune-invasive phenotype helps the
bacteria adapt to rapidly changing host environment. LOS oligosaccharide
side chains terminate in epitopes that mimic sugar moieties of mammalian
glycosphingolipids. This form of molecular mimicry not only provides the
bacterium with a method of immune avoidance but also allows the bacterium
to use host-derived molecules that normally associate with the mimicked
structure.

C. Type IV Pilus
The N. gonorrhoeae pilus protein is one of the major antigenic
determinants on the gonococcal cellular surface. Gonococcal pili are surface
appendages composed of identical polypeptide subunits termed pilin,
which polymerize to form linear structures, about 1,000-4,000 nm in
length. The major structural subunit, the pilin or PilE protein, assembles into a
helical pilus fiber and tip of the pilus is decorated with the adhesin, PilC (83).
The pilus is a highly variable structure on the gonococcal surface; the pilin
protein undergoes both antigenic and phase variation. Phase variation occurs
during DNA replication in a RecA-independent manner. The pilE gene has a
poly C tract located at the beginning of the gene; during replication DNA
polymerase can add/delete a C, thus causing frame-shifting and the gene to be
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turned on or off (105, 240). Multiple pil loci exist within the genome,
antigenic variation occurs when high frequency, enabling recombination to
occur between expressed pilE gene with many silent pilS gene copies (129,
130). The pilE recombination event is non-reciprocal and RecA-dependent
(77, 105, 189). Posttranslational modifications provide additional sources for
PilE structural and functional diversity. Three distinct posttranslational
modifications have been described; they include glycosylation (222),
phosphoethanolamine modification (85), and phosphorylcholine modification
(85, 227).
Several studies have suggested a role for PilE in receptor recognition, as
different antigenic forms of PilE influence the adherence of Neisseria to
epithelial cells and tissue tropism. Type IV pili of Neisseria gonorrhoeae
and Neisseria meningitidis mediate the first contact to human mucosal
epithelial cells, an interaction which is also critical for the interaction with
vascular endothelial cells. Pili bind epithelial cell receptor molecules and
thereby promote mucosal colonization. They also interact with
polymorphonuclear leukocytes and macrophages (104, 181, 184). An
important factor in the pathogenesis of gonorrhea may be the ability of pili to
facilitate attachment of N. gonorrhoeae by overcoming the initial electrostatic
repulsive barrier that exists between the bacterial cell and the host cell (82).
Type IV pili (Tfp) mediate the movement of bacteria over surfaces without the
use of flagella. These movements are known as twitching motility (224).
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Human volunteer infection studies have suggested a possible correlation
between maintenance of virulence in association with piliation status of N.
gonorrhoeae (95). Previous studies have suggested the cell surface protein CD46
as a receptor for neisserial pili on human epithelial cells (93).
However, recent studies point out pilus-mediated gonococcal infection of
epithelial cells can occur in a CD46-independent manner (98, 99), thus
questioning the function of CD46 as an essential pilus receptor for pathogenic
Neisseriae.

D. Opacity (Opa) proteins
The Opa (opacity) proteins are a family of antigenic- and phase-variable
integral outer membrane proteins, found in the pathogenic Neisseria. According
to the predicted protein structure, the proteins are comprised of eight membrane
spanning domains with four surface- exposed loops (120). Opa proteins were
originally identified by their ability to confer opacity and color changes to
colonies of N. gonorrhoeae grown on translucent agar when they are viewed
under diffused light with a stereomicroscope (66). It was demonstrated that the
intravaginal inoculation of female mice with gonococci of an Opa− phenotype
results in their conversion to an Opa+ phenotype; these proteins are important for
gonococcal survival and pathogenesis (91, 104).
Eleven opa genes are possessed by Neisseria gonorrhoeae, while Neisseria
meningitidis only has four opa genes. The Opa proteins are subject to high
frequency phase variation and express up to 0-4 Opas at a time (9, 13). The
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changes in the number of poly CTCTT coding repeats (located in the signalencoding region of the genes) leads to phase variation. Slipped-strand mispairing
affects changes in the CTCTT repeats, resulting in translational frame shifts, so
that multiple or one Opas are expressed at a time (91, 143).
The Opas mediate a tight secondary attachment with the epithelial cells of the
urogenital mucosa; they also have two host cell receptors: heparin-sulfate
proteoglycans (HSPG) and carcinoembryonic antigen-like molecules
(CEACAMS) (44, 60, 75, 223). The interaction of Opa proteins with CEACAM,
on host neutrophils leads to down regulation or death of host immune cells (44).
When Opas interact with phagocytes, they trigger signaling cascade such that Srcfamily tyrosine kinases and small G-protein Rac1 are activated, thereby
facilitating the intracellular accommodation and survival of gonococci in
professional phagocytes (80, 195).

E. IgA Protease
IgA1 is the most abundant IgA subtype on human mucosal surfaces and is
generated by mucosal lymphocytes. All pathogenic Neisseria secrete one of two
closely related types of IgA1 proteases. The secreted enzyme cleaves human
IgA1, but not IgA2. The IgA1 proteases are useful in cleaving IgA1 molecules to
yield intact Fc and F(ab) fragments (140). Cleavage of intact IgA1 results in the
loss of Fc-mediated secondary effector functions, such as inhibition of adherence
and the retention of antigen-binding activity by the F(ab) fragments. It has been
hypothesized that F(ab) fragments may simultaneously block the binding of intact
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(functional) antibodies of IgA or other isotypes to bacterial epitopes and
thereby inhibit complement activation and bacteriolysis (83).
The potential role(s) of the IgA1 proteases may extend beyond cleavage of
IgA1. Human LAMP1 (hLAMP1), a major integral membrane glycoprotein of
lysosomes, can be cleaved by IgA1 protease (4, 79) and thereby help in
gonococcal transepithelial trafficking (88, 115) and inhibition of TNF-αmediated apoptosis (6). Since IgA1 is thought to be the predominant antibody
subclass protecting mucosal tissues against microorganisms, the cleavage of
IgA1 by the neisserial enzyme might impair the local mucosal immune
function (212).

F. Reduction Modifiable Protein (Rmp)
Reduction modifiable protein is a surface exposed outer membrane protein
expressed by Neisseria species. This protein shows homology to OmpA of E.
coli and after reduction and SDS-PAGE analysis the protein shows a shift in
molecular weight, thereby earning its name (74). It is unique among the
major outer membrane antigens of the gonococcus, as it differs from the other
surface-exposed gonococcal outer membrane proteins by its high degree of
intrastrain and interstrain homology in molecular weight, structure, and
immunology (119). Rmp appears to be stably associated with porin and LOS,
even after being subjected to harsh dissociating conditions (86, 125). It was
shown that antibodies produced against Rmp inhibit the binding by anti-porin
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and anti-LOS antibodies, thus reducing bactericidal activity by the serum.
Rmp may act to promote infection in the host by Neisseria (15).

V. Iron availability in the human host
Iron is an essential element for most organisms, including bacteria, with the
exception of the bacterial genera Lactobacillus and Borrelia. It is contained in many
redox enzymes of the intermediary metabolism and in membrane-bound electron
transport chains of respiratory systems and photosynthesis. Iron is perfectly suited for
its role in electron transport chains because of the wide range of Fe2+/Fe3+ redox
potentials from −300 to +700 mV, depending on the iron ligands and the protein
environment (25).
However, despite its abundance on earth, and the micromolar concentrations
required for cell growth, it is biologically unavailable in most environments. In
aerobic inorganic environments, iron is present essentially in the oxidized ferric form
Fe3+, which aggregates into insoluble oxy-hydroxide polymers. When reduced, the
Fe2+ activates the Fenton reaction (Fe2+ + H2O2 → Fe3+ + OH− + OH), leading to the
partial reduction of oxygen into hydroxyl radicals that are deleterious for most
macromolecules as they damage DNA, lipids, and proteins (222). Protection against
iron is achieved by iron sequestration into carrier proteins. To avoid Fenton
chemistry, iron must be carefully chaperoned through the body by human serum
transferrin (hTf) where it is solubilized and stabilized as Fe3+ or stored in ferritin. The
various iron carrier proteins in the host are:
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A. Transferrin
Transferrin (Tf), an iron transport protein, is found in serum, lymph and
seminal fluids. It has an approximate molecular weight of 80kDa and is a
bilobed glycoprotein (225, 134). Each lobe of Tf (N- and C- lobe) is capable
of binding of two atoms of iron, and each lobe contains two domains. X-ray
crystal structures reveal that the two similarly folded globular lobes are
divided into two domains by a large cleft that carries the iron binding site
(225). Tf is present in substantial levels (25–44 μM) in serum, but is only a
minor component (0.2–1.3 μM) of mucosal secretions (185). In serum, the
iron saturation of Tf is usually 30%, with iron primarily occupying the N-lobe,
and the level of iron saturation can be reduced substantially during infection
(239). Tf has both an iron transport function and a protective function against
iron toxicity. Iron-bearing hTF in the blood binds tightly to the
specific transferrin receptor (TFR). After undergoing endocytosis,
acidification of the endosome initiates the release of Fe(3+) . Iron-free hTF is
recycled back to the cell surface and it is released to sequester more iron
(117).
B.

Lactoferrin
Lactoferrin (Lf) is a non-haem iron-binding protein that is found in
mucosal secretions, including tears, saliva, vaginal fluids, semen and released
by leucocytes at sites of inflammation (73). Lf exhibits an extremely high
affinity constant for the FeIII ion (Ka -1020 M−1) compared to affinity constant
for FeII (103 M−1). Lf is structurally very similar to Tf and is an 80 kDa
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glycosylated protein, but differs in that it is capable of retaining iron under
acidic conditions (pH < 6) (225). Lf is present at very low levels in serum
(3.8–8.8 nM) but is a significant component of mucosal secretions (6–13 μM)
(185). Lf plays a key role in maintaining cellular iron levels in the body and
in Fe3+ homeostasis. The antibacterial activity of Lf is due to its ability to take
up the Fe3+ ion, limiting use of this nutrient by bacteria at the infection site
and inhibiting the growth of these microorganisms as well as the expression of
their virulence factors. Lactoferrin is a modulator of the innate and acquired
immune systems. Depending on the immune status of an individual, Lf can
have anti-inflammatory properties that down regulate the immune response
and prevent septic shock and damage to tissues (73).
C. Ferritin

In the human host, ferritin is the major iron storage protein. Ferritins
constitute a broad superfamily of spherical, shell-like iron-storage proteins
and are composed of 24 protein subunits that form a hollow sphere. The
majority of iron in the body is stored intracellularly in ferritin (up to 4,500
Fe3+ atoms per ferritin molecule). Ferritin protects eukaryotic cells from the
toxic effects of iron accumulation. It also stores iron, making it available in
case of iron shortage. Following cell lysis, ferritins are also found in plasma
(169, 225).
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D. Heme binding proteins
Heme bound to hemoproteins constitutes the major iron reservoir in
mammalian hosts and is the preferred iron source of bacterial pathogens.
Hemoglobin is located in red blood cells, where it functions as the oxygen
transporter. It is a tetramer with two α- and two β-chains. Each subunit binds a
heme molecule. Haptoglobin is a serum tetrameric glycoprotein. In serum,
haptoglobin binds the hemoglobin, released by hemolysis, with a high affinity.
The haptoglobin-hemoglobin complex is an iron source for several bacteria
like Neisseria meningitidis, and Haemophilus influenzae (225). Heme, the iron
protoporphyrin IX molecule, is a prosthetic group for many enzymes. It is a
protoporphyrin source for several species, including Enterococcus
faecalis, Lactococcus lactis, and Haemophilus influenzae (225).
VI. Iron acquisition Systems

Iron acquisition is accomplished by microorganisms via two general mechanisms:
iron acquisition by cognate receptors using low molecular weight iron chelators
termed siderophores and receptor-mediated iron acquisition from host proteins. The
first mechanism relies on siderophores, synthesized and released by bacteria into the
extracellular medium. The second involves direct contact between the bacterium and
the exogenous iron sources using specific host-iron binding protein receptors. The
main difference between these two mechanisms is that siderophores and heme can be
taken up by the bacterial cell as intact molecules whereas iron must be extracted from
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host carrier proteins such as transferrin or lactoferrin prior to being transported into
the bacterial cell.
The uptake of iron from transferrin, lactoferrin, hemoglobin, and siderophores has
been identified in both Gram-negative and Gram-positive bacteria. Transferrin,
lactoferrin, hemoglobin, and most ferric-siderophore complexes exceed the molecular
weight cut off of porins and thus require specific outer membrane receptors for
uptake into the periplasmic space. These high-affinity outer membrane receptors
share some common characteristics. They have a low level of primary sequence
homology that is most pronounced in their amino termini, and their transport function
depends on a complex of three proteins localized in the cytoplasmic membrane
(TonB, ExbB, and ExbD) that we call the TonB complex (225). Gram-negative
pathogens use a variety of transporters to access the host iron sources. For example in
V. cholerae, iron bound to haem/hemoglobin is actively transported into the cell via
ligand-specific outer membrane receptors (128, 203), in E. coli iron bound to organic
acids like citrate is utilized by FecA transporter (24), Haemophilus influenzae and H.
haemolyticus acquire iron bound to human transferrin through specific transporters
(138).
Siderophores (from the Greek: “iron carriers”) are defined as relatively low
molecular weight, ferric ion specific chelating agents elaborated by bacteria and fungi
growing under low iron stress. The role of these compounds is to scavenge iron from
the environment and to make the mineral available to the microbial cell (148). More
than 500 different siderophores, mostly produced by Gram-positive and Gram22

negative bacteria, have been described. Despite this great variety, most have a peptide
backbone with several nonprotein amino acid analogs. Based on their iron ligation
groups, siderophores have been tentatively classified into three main chemical types:
hydroxamates (e.g. aerobactin), catecholates (e.g. enterobactin), and hydroxyacids
(e.g., pyochelin) (169, 225).
A common pattern of bacterial siderophore transport systems in Gram-negative
bacteria has been identified. An outer membrane transporter binds the Fe3+siderophore complex. The barrel of the transporter, consisting of 22 β-strands and an
inside plug, binds the iron complex in the barrel entrance. Internalization of this
complex is an energy-dependent process, with the TonB-ExbB-ExbD complex
providing the energy (25). Many bacteria are able to utilize siderophores produced by
other organisms, so-called xenosiderophores. For example, E. coli K-12 can utilize
the fungal siderophores ferrichrome and coprogen and citrate in addition to it own
siderophore enterobactin. In E. coli multiple receptors have been identified and their
crystal structures have been solved. Some of them are FepA (enterobactin) and FhuA
(ferrichrome) (23, 39).

VII.

TonB-Dependent Transporters
In Gram-negative bacteria, transport of siderophores into the periplasm is
mediated by TonB-dependent receptors (68, 225). TonB-dependent transporters have
also been well characterized in iron acquisition pathways mediated by host-iron
binding proteins (52, 188, 194).
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TonB-dependent transporters share a common topology. They all are composed of
two characteristic domains: (i) a C-terminal beta-barrel (spanning the outer
membrane), comprised of 22 amphipathic, antiparallel β-strands, and a globular plug
domain, located at the N-terminal position and is folded up inside the barrel (55, 68,
107). The plug domain of the outer membrane receptor contains a conserved, 7 amino
acid sequence: the TonB-box. The TonB box is found at the N terminus of the plug
domain and in some structures protrudes into the periplasm. In other structures, the
TonB box is tucked up into the plug domain within the barrel or is disordered and not
visible in the structures (22, 30, 225). This conserved region adopts a variety of
conformations, ranging from folded to unfolded, and is believed to participate in
interactions between TonB and the TonB-dependent transporter and is the primary
signature of TonB dependence (152, 162).
The energy that is required for the active transport of iron-laden substrates
through the TonB-dependent outer membrane receptor is provided by
the TonB/ExbB/ExbD complex, which is located in the cytoplasmic membrane. The
TonB protein complex harnesses energy generated by the proton motive force in the
inner membrane, and then transduces it to the outer membrane (100, 107, 161). The
binding of iron-bound ligand to the extracellular pockets of outer membrane receptors
causes a TonB-independent allosteric transition that is propagated through the outer
membrane. This results in formation of a transmembrane channel within the receptor,
through which the ligand permeates into the periplasm. Upon arrival in the periplasm,
siderophores are rapidly bound by specific periplasmic binding proteins, and shuttled
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to distinct ABC transporters embedded within the cytoplasmic membrane for
transport into the cytoplasm (68, 106, 135).
TonB-dependent uptake systems permit bacterial growth in a wide range of ironlimited environments. These systems are also considered targets for novel antibiotics,
because they contribute to the specific permeability of the Gram-negative cell
envelope (135).
VIII. Iron Acquisition in Pathogenic Neisseria
Two general mechanisms of iron acquisition in bacteria have been described:
siderophore-mediated iron acquisition by cognate receptors and receptor-mediated
iron acquisition from host iron-binding proteins. Many enteric bacteria use
siderophore-mediated iron uptake. In Neisseria, however, there is no known
production of siderophores (185, 231). Still enterobactin and aerobactin have been
shown to support the growth of pathogenic Neisseria. To overcome the iron limited
host environment, these highly adapted obligate human pathogens can efficiently
utilize multiple host iron (Fe) sources, allowing replication on mucosal surfaces, in
the bloodstream, and intracellularly. Pathogenic Neisseria express multiple highaffinity iron transporters to acquire iron from transferrin, lactoferrin and hemoglobin
(113, 132, 187). Although these receptors may vary in complexity and composition,
all three systems are structurally similar in consisting of an outer membrane TonBdependent transporter and an accessory lipoprotein.
The transferrin binding proteins and the receptor complex are discussed in detail
in the next chapter. The lactoferrin iron utilization system is made up of lactoferrin
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binding proteins A and B (LbpA and LbpB). LbpA is the TonB-dependent transporter
and essential for iron internalization, LbpB is a lipoprotein and not required for
lactoferrin iron utilization. The HpuAB receptor is responsible for utilization of iron
from hemoglobin and hemoglobin-haptoglobin. The receptor is made up of HpuB
and HpuA; both of which are required for iron internalization. HpuB is an 85 kDa
TonB-dependent outer membrane transporters and HpuA, is a 34.8 kDa lipoprotein
(156). To utilize iron bound to hemoglobin, only Neisseria meningitidis expresses the
HmbR hemoglobin receptor. HmbR is an iron-regulated 89.5 kDa outer membrane
protein that mediates iron acquisition from hemoglobin but not from hemoglobinhaptoglobin (204).
IX. Gonococcal Transferrin Receptor
The neisserial transferrin–iron import system consists of two dissimilar transferrin
binding proteins, TbpA and TbpB. The neisserial receptor involved in iron acquisition
from human Tf is preferentially expressed under conditions of iron deprivation (49,
189). The tbpA and tbpB genes are arranged in a bicistronic operon, with the tbpB
gene located upstream of tbpA (52, 112, 178). The two genes are separated by an 86
base pair region, potentially capable of forming a stem-loop structure in the mRNA.
Using lacZ fusion and RT-PCR approaches, under iron-stressed conditions, it was
shown that there are twice as many tbpB-specific transcripts as tbpA-specific
transcripts, yielding an apparent tbpB/tbpA ratios of approximately 2:1 (178). This
implies that the secondary structure of the intergenic region might function in
maintaining transcript stoichiometry (178). The tbpAB promoter contains a Fur
binding site and is under the control of the Fur protein. Fur (ferric uptake regulator) is
26

a global regulator, which in the presence of iron represses gene transcription. This
regulatory mechanism leads to preferential expression of Tbps under iron-limited
conditions.
TbpA is an integral outer membrane protein that provides the pore through which
iron is transported across the outer membrane of gonococci (52). Recently, the crystal
structures of components of the meningococcal transferrin–iron uptake system were
reported (31, 151). TbpA is conserved in pathogenic Neisseria and shares similarity
with other TonB-dependent outer membrane proteins (166, 171). Similar to the
solved crystal structures of many such transporters, the TbpA structure is
characterized by a C-terminal beta-barrel domain comprised of 22 amphipathic betastrands and an N-terminal globular plug domain that is folded up inside the betabarrel (150). The TonB-dependent transporter is energized by TonB and ExbB and
ExbD (106, 150). Gonococcal mutants not expressing TbpA were capable of binding
some transferrin but incapable of growth on transferrin as the sole iron source (48,
52), making TbpA essential for transferrin-iron uptake.
The second member of the transferrin-iron uptake system is TbpB, which is a
lipid-anchored protein, presented on the outer leaflet of the outer membrane. TbpB is
capable of binding transferrin (1, 112). TbpB is not essential for iron acquisition but
makes the process more efficient (1). TbpB is capable of discriminating between apoand holo-transferrin and preferentially binds holo-transferrin. Gonococcal TbpB
mutants showed decreased iron-uptake from transferrin but grew with transferrin as a
source of iron (1). TbpB has the ability to affect rapid association and dissociation of
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transferrin on the cell surface, thereby allowing optimum ligand to be delivered to
TbpA and once the iron has been removed from the ligand, to aid in the release of
apo-Tf (63). TbpB may also participate in deferrating transferrin (191) and work in
concert with TbpA to make the transferrin-iron acquisition process more efficient.
In the gonococcal iron internalization process (figure 1), transferrin binds to TbpA
and TbpB on the outer membrane. The cytoplasmic membrane TonB-ExbB-ExbA
protein complex interacts with the TonB box sequence in the TbpA plug domain. Iron
is stripped from transferrin, in an energy dependent process, and translocated through
the TbpA barrel into the cell periplasm. Iron is then bound to apo-FbpA, a
periplasmic iron binding protein, which shuttles the iron across the periplasm to the
cytoplasmic membrane. The inner membrane FbpB-FbpC permeases transport iron to
the cytoplasm in an ATP dependent manner (figure 1).
Several studies have demonstrated that TbpA and TbpB function together for
extracting iron form holo-transferrin. Evidence of complex formation between TbpA
and TbpB has been described in the pathogenic Neisseria. Using radiolabelled
transferrin binding assays, it was demonstrated in Neisseria meningitidis, that TbpA
and TbpB did form a complex (160). Studies utilizing photon correlation
spectroscopy (19) to analyze complex formation in N. meningitidis have concluded
that affinity purified TbpA and TbpB physically associate with each other. Results of
transferrin-binding affinity purification, and protease accessibility experiments
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Figure 1: Schematic model of the transferrin iron acquisition system in Neisseria
gonorrhoeae. The transferrin iron acquisition system is composed of two transferrin binding
proteins, the surface exposed TbpA and TbpB. TbpA is a TonB-dependent transporter, serving as
a channel for iron internalization. TbpB is an accessory protein, tethered on the outer leaflet of
the outer membrane through its lipid moiety. Ferrated transferrin binds to the Tbps and iron is
removed and internalized in an energy dependent manner, the energy is supplied by the TonBExbD-ExbB complex by TbpA-TonB interaction. Iron is internalized and in the periplasm binds
the periplasmic binding protein, FbpA; it is then shuttled across the periplasm to the FbpB-FbpC
permease complex in the inner membrane, which then brings the iron into the cytoplasm in an
ATP-dependent step.
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showed that both TbpA and TbpB function together in the wild type gonococcal
strain and both of the Tbps together show binding conformations that are distinct
than those expressed by either of the Tbp alone in the mutant. The protease exposure
of TbpB was affected by the energization of TbpA, consistent with an interaction
between these proteins (48, 54). Co-immunoprecipitation assays have suggested that
TbpA and TbpB may interact with one another on the cell surface. TbpA-specific
antibodies were able to co-immunoprecipitate TbpB from outer membrane fractions,
even in the absence of transferrin (96), suggesting that even in the absence of
transferrin the two proteins associate with each other. Recent reports of complex
crystal structures and electron microscopy analysis, have proposed the Tbps
functioning together to bind and extract iron from transferrin (150).

X. Gonococcal Vaccine Development
The new superbug Neisseria gonorrhoeae has maintained resistance to previously
described antibiotics and developed resistance to ceftriaxone, the last remaining
option for treating gonorrhea (214). The rise in untreatable gonorrhea poses an
exceedingly serious public health problem. No vaccine to protect against gonorrhea is
available. Progress in developing a vaccine has largely been stymied due to antigenic
variation displayed by the organism, coupled with the host's inability to generate a
protective immune response (84). Gonococci are well-adapted pathogens since many
of its surface antigens like pilin and opacity proteins undergo high frequency phase or
antigenic variation, making the surface of the gonococcus difficult to target for a
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protective immune response. Much vaccine work has focused on surface exposed
antigens that clustered in the outer membrane, like porins, pili, and Rmp. A trial of a
purified gonococcal pilus vaccine composed of a single pilus type was tested in male
volunteers. This gonococcal pilus vaccine composed of a single pilus type failed to
protect men against gonococcal urethritis (18) possibly due to antigenic variation.
Porin was evaluated as a vaccine candidate as it does not undergo phase variation, is a
major outer membrane protein and is important for invasion. The results were
unsuccessful as sialylated LOS partially masks adjacent porins and reduces antibody
binding to porins. Rmp elicits blocking antibodies that subverts anti-porin antibodies
(175, 232, 241).
Utilizing proteins involved in iron acquisition as vaccine candidates seems
rational as iron is critical for Neisseria survival. The Tbps are attractive vaccine
candidates because they are not subject to high frequency phase or antigenic
variation, are surface exposed, and are expressed by all clinical strains (132). In a
study with human male volunteers, intraurethral inoculation with Tbp− mutant strain
was incapable of initiating urethritis, indicating that Tbps are necessary for
establishment of infection in human male infection model (53). Analysis of intranasal
immunization with recombinant Tbp proteins conjugated to the cholera toxin B
subunit showed that these antigens elicited antibody responses in the serum and
genital tract of female mice (164). The results reported strengthen the proposal to
include components of the neisserial transferrin receptor in vaccine candidates.
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XI. Research Objectives
A number of reports have together contributed to the study of iron utilization from
human transferrin in the Neisseria species. Studies, in the past, have attempted to
decipher the gonococcal transferrin receptor and provided several indirect lines of
evidence demonstrating complex formation between the Tbps. Previous studies in our
lab have generated hemagglutinin (HA) epitope insertion mutants in TbpA and TbpB,
to investigate the surface-exposed regions in the Tbps. The Hemagglutinin (HA)
epitope tag was inserted in a number of conserved and variable regions of TbpA and
TbpB, with the intention to study structure-function relationships between the Tbps.
The overall goal of the proposed studies here was to probe the structure-function
relationships in both the Tbps in order to determine the important domains for
interaction between the two Tbps, thereby yielding important information for a
rational design of a vaccine against gonococcal infections. First we examined the iron
binding properties of the conserved EIEYE sequence in the TbpA plug domain, with
the intention of extending our knowledge about transferrin-iron internalization
through TbpA. Secondly, we utilized photoactivable cross-linkers to assess the effect
of TbpA on TbpB in the gonococci and studied it in presence of ligand and TonB
derived energy. We employed insertion mutants, in which TbpA contained the
hemagglutinin (HA) epitope tag, to probe for impact of TbpA on TbpB. And lastly,
we sought to characterize the importance of TbpB regions in the functional and
structural relationships of TbpB .
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This study will help to elucidate additional characteristics of the interaction
between the gonococcal Tbps in vivo. By looking at the structural and functional
properties of the two members of the gonococcal transferrin receptor, we will have a
better understanding of mechanisms of iron acquisition through the Tbps. The Tbps
have a potential to be vaccine candidates and knowledge derived from our study
might be important for the rational design of a vaccine comprised of one or both of
the transferrin binding proteins.
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CHAPTER 2: Materials and Methods
I. Bacterial Growth Conditions
A. Strains and media
The N. gonorrhoeae strains used in this study are listed in Table 3. Gonococci were
routinely maintained on GC medium base (Difco) containing Kellogg’s supplement 1 (94)
and 12 μM ferric nitrate (Supplement II) at 37oC in a 5% CO2 atmosphere. For growth under
iron-stressed conditions, which allows for maximal expression of transferrin binding
proteins, liquid cultures of gonococcal strains were grown in acid-washed glassware
containing chemically defined media (CDM) (137, 230). The CDM was rendered iron free by
treatment with Chelex 100 (BioRad). Plasmids were propagated in TOP10 (Invitrogen) E.coli
strains, grown at 37oC in Luria-Betani broth (7,8), supplemented with 50μg/ml of kanamycin
(Sigma).
B. Bacterial growth in photoreactive CDM Media
Photoreactive amino acids L-Photo-Leucine and L-Photo-Methionine (Thermo Scientific)
were used as cross-linking reagents. To the liquid chelexed defined medium (CDM)
photoreactive amino acids were added at a final concentration of 0.7 mM photo-leucine and
0.1mM photo-methionine. Bacterial cultures were grown in a shaking incubator at 37°C, in
an atmosphere supplemented with 5% CO2. After four hours of growth, cultures were UV
irradiated and standardized to culture density.
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Table 3: Neisseria gonorrhoeae strains

Strain

Phenotype (genotype)

Reference/Source

Neisseria gonorrhoeae strains

FA19

Wild type (TbpA+ TbpB+)

(131)

FA6747

TbpA− (tbpA::mTn3cm)

(52)

FA6905

TbpB− (ΔtbpB)

(48)

MCV515

L9HA (750) TbpA Lbp- (tbpA HA lbpB::Ω)

(238)

MCV519

L11HA (843) ΔAla847 TbpA Lbp- (tbpA HA lbpB::Ω)

(238)

MCV523

β16HA (713) TbpA Lbp- (tbpA HA lbpB::Ω)

(238)

MCV527

L2HA (229) TbpA Lbp- (tbpA HA lbpB::Ω)

(238)

MCV260

TbpAE120AY121AE122ATbpB+

(153)

MCV814

HA4 (293) TbpB Lbp- (tbpA HA lbpB::Ω)

(62)

MCV822

HA8 (607) TbpB Lbp- (tbpA HA lbpB::Ω)

(62)

MCV839

TbpB LSAC (lbpB::Ω)

(157)

MCV843

TbpB Δgly (lbpB::Ω)

(157)
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II. Recombinant Protein Expression and Purification

A. Recombinant tbpA (WT) and tbpA (EYE120AAA) plug protein expression
Starter cultures of E. coli expression strain BL21 (DE3) (containing the wildtype
and mutagenized tbpA plug-encoding domains) were grown in LB media containing
100 μg/ml Ampicillin, for approximately 4 hours at 37oC. After growth, the starter
cultures were centrifuged at 5000 x g for ten minutes and the bacterial cell pellet was
resuspended into fresh LB media with 100 μg/ml ampicillin. The freshly resuspended
starter cultures were then used to inoculate 1L of LB broth with 100 μg/ml ampicillin.
The cultures were incubated at 37oC with a constant shaking at 225 rpm. When the
cultures reached an O.D. between 0.4-0.8, protein expression was induced with the
addition of 1mM IPTG (isopropyl-B-D-thiogalactopyranoside) (Sigma). The cultures
were allowed to induce for four hours at 37oC with a constant shaking at 225 rpm.
After the induction, the cultures were allowed to centrifuge at 8000 x g for 25
minutes. The supernatant was discarded and the pellets were resuspended in sterile
1X PBS (pH 7.2) and centrifugation was performed at 9000 rpm for 20 minutes. The
supernatants were removed and the bacterial pellets were dried and stored at -20oC
overnight.

B. tbpA (WT) and tbpA (EYE120AAA) plug protein purification
The bacterial pellets were thawed on ice and resuspended in Lysis buffer (50mM
NaH2PO4, 300 mM NaCl, 10mM Imidazole, at pH 8.0). Lysozyme and His-tagged
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Protease Cocktail inhibitor (Biorad) was added at a concentration of 1mg/ml and
1ml/20gms respectively. The cell pellet was resuspended and allowed to incubate for
30 minutes on ice. The cellular mixture was sonicated and the lysate separated from
the debris by centrifugation at 10000 x g for 30 minutes at 4oC. The supernatant was
then incubated with 50% Ni-NTA slurry (Qiagen) overnight at 4oC. Then, the next
day the mixture (containing the Ni-NTA resin) was added to a column and the first
flow-through fraction was collected in a fresh tube. The resin in the column was
washed twice with 5ml of Wash Buffer (50mM NaH2PO4, 300 mM NaCl, 20mM
Imidazole, at pH 8.0) and collected in two separate tubes. The recombinant proteins
were eluted from the resin-column with the elution buffer (50mM NaH2PO4, 300 mM
NaCl, 250mM Imidazole, at pH 8.0). The purified proteins were dialyzed against
2000 fold 1X PBS (pH 7.2).

C. SDS-PAGE, protein transfer and detection of purified protein
The various purified protein fractions were solubilized in 2X Laemmli
solubilizing buffer (109). The samples were then heated at 100oC for 2 minutes after
the addition of 5% β-mercaptoethanol. After allowing the heated samples to cool,
they were loaded on to a 15% gel and subjected to sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) (109). The separated proteins were
then transferred to a nitrocellulose membrane at 28mAmp for 16 hours in 20mM Tris
base, 150mM glycine and 20% methanol (211).
For detection of His-tagged purified recombinant proteins, the nitrocellulose
membrane was blocked with 5% skim milk in low-salt Tris-buffered saline (LS-TBS).
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Blots were probed with anti-His-tag monoclonal antibodies (Calbiochem) at a dilution
of 1:1000, as primary antibody the blots were then washed with LS-TBS containing
Tween-20 and then probed with goat-anti-mouse IgG AP (BioRad) at a 1:5000
dilution NBT/BCIP (Sigma) was used for developing and visualizing the protein
bands on the membranes.

D. Coomassie blue staining
To detect purified protein bands, the SDS-PAGE gels (with the separated
proteins) were stained with Coomassie blue (0.25% Coomassie R-250, 50%
methanol, 10% glacial acetic acid) the gels were left in the blue stain solution
overnight at room temperature. The gels were destained in 20% methanol and 5%
acetic acid at room temperature till the background was destained and the protein
bands visualized.

III. Immunoblotting and Detection
A. Preparation of whole cell lysates
To evaluate the expression of Tbps, gonococcal cultures were grown in CDM
under iron-depleted conditions. After four hours of growth, cultures were
standardized to constant cell density. Samples were centrifuged at 14000rpm for
10mins. Cell pellets consisting of approximately 1 x 1012 cfu were resuspended in 100
μl of 2X Laemmli solubilizing buffer (109).
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B. SDS-PAGE and protein transfer
Prior to gel analysis 2µl of benzonase nuclease (Sigma) was added to the whole
cell lysates and incubated for 10 minutes at room temperature, to decrease the
viscosity of the prepared cellular lysates. After the incubation 5% βmercaptoethanol (Sigma) was added to the whole cell lysates and they were
heated at 95°C for 2 minutes. Samples were allowed to cool down to room
temperature and centrifuged for 30 seconds at 14000 rpm. Samples were analyzed
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on a
7.5% polyacrylamide gel using a Mini-Protean III apparatus (Biorad). Separated
proteins on the gels were transferred to nitrocellulose membrane (Schleicher and
Schull) in 20mM Tris base, 150mM glycine and 20% methanol in a submerged
transfer apparatus (Biorad) at constant current of 28mAmp for 16 hours.
Before western blotting, to confirm equal protein loading in each lane, the
nitrocellulose membranes were stained with Ponceau S solution (0.1% w/v
Ponceau S, 5% acetic acid) for 10-12 minutes and excess stain rinsed with
distilled water.

i) TbpA detection
To detect TbpA nitrocellulose membranes were blocked with 5% BSA in
high salt Tris-buffered saline (HS-TBS: 20mM Tris base, 500mM NaCl). The
blocked membrane was probed with 1:1000 dilution of primary anti-TbpA
polyclonal antibodies for 1 hour as described (48). The primary antibody was
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detected with a goat anti-rabbit antibody conjugated to alkaline phosphatase
(Biorad) at a dilution of 1:5000 for 1 hour. The membrane was washed in HSTBA with 0.05% Tween-20 (Sigma). Blots were developed using NBT/BCIP
(Sigma) in buffer containing 100 mM Tris (pH 9.5), 50 mM MgCl2, and 100 mM
NaCl.
ii) TbpB detection (using anti-TbpB antibodies)
To detect TbpB, the nitrocellulose membranes were blocked with low-salt
Trus buffered saline (LS-TBS) containing 5% non-fat dry skim milk (Sigma) for
an hour. Membranes were probed with 1:1000 diluted primary anti-TbpB
polyclonal antibodies (163), washed in low salt-TBS and 0.05% Tween-20. Next
the membranes were probed with goat anti-rabbit alkaline phosphatase conjugated
(Biorad) secondary antibody at a 1:5000 dilution. The membranes were developed
with NBT/BCIP developing system.
iii) TbpB detection (using transferrin)
As an alternative method to detect TbpB, we blocked the nitrocellulose
membranes in 5% non-fat dry skim milk (Sigma) and LS-TBS. The membranes
were washed with low-salt TBS and 0.05% Tween-20. To detect transferrinbinding by TbpB, the membranes were probed with horseradish peroxidase
conjugated Tf (HRP-Tf) at a concentration of 1µg/ml for an hour. HRP was
detected using Chemiluminesence (ECL) 2 Western Blotting Substrate kit
(Pierce) (48). Blots were exposed to film to detect TbpB bands bound to
transferrin.
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IV.

Image J analysis
The photo-crosslinked samples were analyzed by SDS-PAGE and separated samples
were transferred to the nitrocellulose membranes. Subsequent to immunoblotting, the
blot images were captured and the band intensities were quantitated using the Image J
1.46r (168) imaging system and associated software.
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CHAPTER 3- DEMONSTRATION OF IRON BINDING BY THE EIEYE SEQUENCE IN
THE TbpA PLUG OF Neisseria gonorrhoeae

I. INTRODUCTION
Neisseria do not produce any known siderophores, however they can utilize
siderophores produced by other microorganisms (28, 67, 182, 183, 231). In the human host
iron is sequestered by a variety of soluble iron-carrying glycoproteins or heme compounds.
Gonococci have evolved mechanisms for obtaining iron from these host iron binding
proteins. To utilize the bound iron, they express high-affinity receptors to utilize iron bound
to human transferrin (16, 67, 111, 126, 131), lactoferrin (16, 67, 111, 126, 133) and
hemoglobin (1,10). The lactoferrin-iron acquisition pathway and the hemoglobin-iron
acquisition pathway are similar to the transferrin-iron acquisition system; all of them
comprised of a TonB-dependent transporter and an outer membrane-tethered lipoprotein (10,
11, 42, 43, 52, 55). Both of these components work together, in a sequential manner, to allow
the iron-binding glycoproteins to interact with the bacterial cell surface, extract iron from the
bound form and internalize it across the membranes.
Gonococci are capable of utilizing human transferrin as a sole source of iron (131),
through the expression of iron regulated transferrin-iron acquisition system. The transferrin
iron uptake system consists of Tf- binding protein A (TbpA) and B (TbpB). TbpA is a
100-kDa integral outer membrane protein, belonging to the family of TonB-dependent
transporters. Tf-binding protein B is an ~80-kDa co-receptor, attached to the outer membrane
by a lipid anchor. TbpA is essential for transferrin-iron acquisition but TbpB is not required
for the same process, instead its presence makes the process more efficient (1). TbpB serves
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as an accessory protein in the iron acquisition process, with a capability of differentiating
between apo- and holo- transferrin (19, 48, 170, 173). Figure 1 depicts the iron acquisition
process in Neisseria gonorrhoeae (27). The process involves the following steps:
TbpA/TbpB recognize and bind holo-transferrin, remove apo-transferrin after stripping iron
(using TonB derived energy), periplasmic FbpA binds iron after it travels through the outer
membrane, FbpA shuttles the iron across the periplasm to the inner membrane permeases
FbpB/FbpC, later transporting it to the cytosol (54, 97, 190)
Recently the crystallization of Neisseria meningitidis TbpA, helped in furthering the
structural study of the neisserial iron import machinery (151). The crystal structures of
several of these transporters have been reported by various groups (31, 150, 155). These
structures are all TonB-dependent transporters, characterized by an N-terminal plug domain
of ∼ 160 residues (plug domain) folded inside a C-terminal 22-stranded beta-barrel domain
(β-barrel domain). The plug domain acts as a ligand sensor, by preventing entry of substances
into the periplasm until the appropriate ligand is bound.
TbpA is significantly larger than other TonB-dependent transporters, the structure
consists of 22 transmembrane β-strands, arranged as a barrel, with long surface exposed
loops, and an N-terminal plug domain. The TbpA barrel is occluded by the N terminal plug
domain. The plug domain does not allow the passage of small molecules through the TbpA
β-barrel. The plug could undergo a conformational change that leads to the ejection of the
plug domain into the periplasm, thereby forming an entry pathway for the iron cargo directly
through the outer membrane transporter.
Previous studies have shown the significance of the TbpA plug domain in the iron
internalization process (238), however the precise mechanism is unknown. In the plug
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domain of TbpA the sequence EIEYE (118-122) is highly conserved (figure 2). The triple
alanine substitution of the Glu120, Tyr121 and Glu122 in a TbpA mutant (EIAAA 118-122)
showed an 80% reduction in transferrin bound iron utilization (153). This demonstrated the
importance of the EIEYE sequence in the TbpA plug in transferrin iron utilization. The
EIEYE motif is well conserved and is suitable for coordinate-covalent bonding to Fe and
capable of scavenging available iron in the iron deprived host milieu. We hypothesize, that at
the TbpA/TbpB surface, iron released from transferrin, is bound by the TbpA plug sequence
(EIEYE) and is transported through β-barrel of TbpA across the outer membrane. In this
study in vitro and in silico experiments were conducted, utilizing wild-type and triple alanine
mutated (EIEYE-EIAAA) recombinant TbpA plug samples, and three small peptides (S1, S2,
S3); each peptide containing the putative iron-coordinating site and specific portions of the
wild-type TbpA plug domain.

II. RESULTS

To study the protein characteristics of the recombinant TbpA plug proteins, we first
undertook large scale growth of the E. coli strains expressing the recombinant plug proteins
(5), and then purified them using the His-tag purification protocol. Protein concentration for
the purified wild type recombinant TbpA plug protein was 18.18 mg/ml and for the mutated
recombinant TbpA plug protein was 42.02 mg/ml. After characterizing them for quality and
protein concentration (figure 3), we examined the secondary structure of the plug (without
the barrel). First, CD spectra analysis of the wild-type and mutated recombinant TbpA plug
protein was carried out. The CD spectra for the wild-type and mutated recombinant TbpA
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Figure 2: Iron coordinating residues in the TbpA plug. In the sequence alignment of TbpA
plug domains from bacterial pathogens, the first two letters preceding the amino acid sequences
represent the genus and species of the bacterial pathogen: Ng, Neisseria gonorrhoeae; Nm,
Neisseria meningitidis; Hi, Haemophilus pleuropneumoniae; Ap, Actinobacillus
pleuropneumoniae; and Mc, Moraxella catarrhalis. The sequences represent mature TbpA plug
domains. Dots indicate identical amino acids, letters indicate specific amino acids and dashes
indicate positions in which gaps were introduced. The inverted triangle represents the site of HA
insertion and the box indicates the conserved sequence motif selected for site-directed, alanine
substitution mutagenesis at amino acids 118 (E), 120 (E), 121 (Y), and 122 (E).
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Figure 3: Characterization of purified wild-type and mutated recombinant TbpA plug
proteins. Proteins were separated on a SDS-PAGE gel and stained with coomassie blue. The
contents of the lanes are: lane1- lysozyme, lane 2-protein molecular weight marker, lane 3- wildtype plug protein, lane 4- mutant plug protein.
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plug protein was centered around 200nm, in the absence of Fe3+. This indicates unfolded
structures for the wildtype and mutated recombinant plug proteins. This was expected
because when the proteins are expressed without the β-barrels, there are no stabilizing
hydrogen bonds formed to induce native secondary structure. This kind of CD spectra has
been previously reported for the recombinant wildtype FbpA plug and the above observation
holds true to that study (191). To investigate an interaction between Fe3+ and the wildtype
and mutated recombinant plug protein, and its consequential conformational change in the
plug, CD spectra studies were carried in presence of Fe3+. The interaction between
recombinant plug domain and its respective cargo has been demonstrated in E. coli (20, 69,
70, 215). The CD spectra for wildtype and mutated plug protein in presence of Fe3+, did not
show any significant change for either of the protein signals. This observation tells us that no
apparent conformational change occurs when (or rather if) binding of Fe3+ happens at the
plug domain.
Fluorescence emission titrations help us to study the binding interactions. In the
system we are studying, we looked at the binding (if any) between the TbpA plug domain
and the peptides with Fe3+. In the fluorescence emission titrations, the 310nm peak was used
as a probe. % quenching (Q%) at 310nm as a function of increasing Fe3+, was measured for
the wild-type recombinant TbpA plug. The conditional Kd for wildtype recombinant TbpA
plug is 10-7M and the Kd value for S1 (peptide) is 10-4M. Upon binding of Fe3+, to the
wildtype recombinant TbpA plug, other amino acids in the TbpA plug could participate to
stabilize the protein- Fe3+ interaction and therefore we probably observed the higher binding
affinity for the wildtype recombinant TbpA plug compared to the peptide S1. The TbpA
wildtype recombinant plug contains four tyrosine residues; the EIEYE sequence in the plug,
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contains one of the tyrosine residues. The S1 peptide under study here contains one tyrosine
residue. Fluorescence emission properties of the S1peptide and the recombinant TbpA plug
depends on these tyrosine residues, with the surface exposed tyrosine residues emitting
fluorescence at 310nm.
The fluorescence emission experiments aid in studying interaction between Fe3+ and
the TbpA plug/peptide, using 310nm peak as a probe, because the binding between the
tyrosine and Fe3+ leads to decrease in free tyrosine in solution and resultant quenching of the
310nm band. In fluorescence emission titration spectra for the wildtype recombinant TbpA
plug, it was seen that the addition of increasing amount of Fe3+, led to the quenching of the
310nm band, indicating a binding event. Similar quenching behavior for the peptide S1was
observed. The Qmax values at the theoretical endpoint of titration, differ for the wildtype
recombinant TbpA plug (Qmax value is approx 40%) and the S1 peptide (Qmax value is 100%).
For the S1 peptide at the end point of titration, Qmax value of approx 100% indicates that all
(in this case 1) tyrosine residues are bound to added Fe3+. The wildtype recombinant TbpA
plug has a Qmax value of approx 40%, indicates that all the tyrosine residues (wildtype
recombinant TbpA plug contains four tyrosine residues) do not participate in Fe3+ binding.
We can speculate that there are two different tyrosine populations, one that participates in
Fe3+ binding (shown by the 310nm band present for quenching), and the other population that
doesn’t show quenching due to non-binding to Fe3+. The S1 peptide contains the EIEYE
sequence and shows 100% binding. The wildtype TbpA recombinant plug containing the
EIEYE sequence, shows a Qmax value of 40%, thereby allowing us to say that EIEYE
sequence is responsible for binding Fe3+ and subsequent quenching of the wildtype TbpA
recombinant plug.
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The predicted structures of the wildtype and mutated TbpA plug of Neisseria
gonorrhoeae were predicted as models, under native conditions through I-TASSER. The top
of the molecule shows the presence of a loop, called the top hat region, which is formed by
the presence of a highly conserved sequence, found prior to the EIEYE motif (figure 4). This
top hat region contains the Ala110 residue, and this residue by HA-insertion tag analysis has
been shown to lie in the surface exposed region of TbpA (238). This tells us that the top hat
region is surface exposed and located at the apex of the molecule. The EIEYE motif is in a
long loop, anchored by beta strands. Prior to binding Fe3+, reorganization of atoms takes
place to maximize binding in the loop; this requires the binding domain to be flexible so as to
utilize minimum energy. The present model, predicts this sequence to be in a flexible loop
and allowing ligand binding. The predicted models of the wildtype and mutated TbpA plug
proteins, show that the EIEYE-EIAAA mutation had the most drastic effect in the surface
exposed top hat region.

III. DISCUSSION
In Neisseria gonorrhoeae, iron bound to human transferrin is acquired in the
following manner: holo transferrin binds to TbpA/TbpB, apo transferrin is recycled from the
TbpA/TbpB surface after stripping iron, iron passes through the β-barrel of TbpA, iron binds
to apo FbpA in the periplasmic side and is transported through the periplasm, it is then
transferred to the cytoplasm with the help of FbpB/FbpC. TbpA, in this iron acquisition
process, must help in removing iron from transferrin and then transporting the iron through
its β-barrel across the outer membrane. A previous study in our lab (154) investigated the
role of TbpA, specifically the TbpA plug in iron acquisition and iron internalization. In vitro
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studies have indicated that the TbpA plug domain functions in iron internalization in the
gonococcal system. Single, double, and triple alanine substitution mutations of the putative
iron-coordinating residues (EYE- residues 120-122) in the TbpA plug domain resulted in
mutants that expressed wildtype levels of TbpA on cell surface and bound transferrin with
wildtype affinity (154). When the double and triple alanine substitution mutants were
analyzed through transferrin-iron uptake assays they showed a significant defect in
internalizing iron. The triple alanine substitution mutant was unable to utilize transferrinbound iron during transferrin-iron utilization growth assays, in absence of TbpB (154). This
demonstrates that the TbpA plug domain and residues EYE are critical for transferrin-iron
acquisition.
The mutagenesis of the TbpA plug domain could have altered iron binding sites,
which may be involved in iron removal from transferrin, and subsequently iron binding by
the plug, and transport across the outer membrane. The substitution mutations in the TbpA
plug domain could have resulted in indirect impacts within the plug binding domain,
resulting in the mutated plug’s inability to bind or transport iron.
TbpA, in addition to being a transferrin receptor, is also an iron transporter. FepA
(TonB-dependent transporter) of E. coli, in the absence of the β-barrel domain, binds directly
to its ligand (ferric-enterobactin) (215). This suggests that the plug is important for ligand
binding and transport. It is possible that in addition to residues 120-122 of the plug domain,
there could be the involvement of other residues/domain in the transferrin-mediated iron
acquisition process. Upon TonB interaction with the TbpA plug, the iron binding site or sites
unravel and facilitate traversal of iron through the outer membrane. This could mean that iron
is coordinated at multiple sites, with movement of iron from one coordination site to the next
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one till it reaches FbpA in the periplasm. FbpA has one iron coordination site. In vitro
recombinant iron binding data shows that TbpA plug domain binds more iron than FbpA,
suggesting that the TbpA plug could bind iron at more than one site.
In this study we set out to test our hypothesis that iron that is released from transferrin
at the TbpA surface binds with the plug sequence (EIEYE) and is transported through βbarrel. We utilized wildtype and triple alanine mutated recombinant TbpA plugs to conduct
in vitro experiments to prove the hypothesis. We started the study with large scale expression
and purification of wildtype and triple alanine substituted recombinant TbpA plug proteins
from E. coli expression strains. Three small peptides (S1,S2,S3) containing the EIEYE
sequence of the wildtype TbpA plug were also synthesized to be used in this study. CD
spectroscopy was used to study the secondary structures of the wildtype and mutant
recombinant plug proteins; the possible change in secondary structure (if any at all) due to
addition of Fe3+ was also studied. The CD data suggested an unfolded structure for both the
wildtype and recombinant plug proteins which could be because the plugs were expressed
without the β-barrel and did not fold into their native conformation. Fluorescence emission
titrations were performed to determine the conditional binding constants of the wildtype and
mutant recombinant TbpA plug proteins. The conditional Kd value for the wildtype
recombinant TbpA plug is 10-7M and for the S1 model peptide is 10-4M. Upon the addition of
Fe3+ both the wildtype recombinant TbpA plug and the S1 peptide showed similar quenching
of the 310nm band, indicating a binding event. No Fe3+ binding was detected for the mutated
(EIEYE-EIAAA) plug (5). This supports our hypothesis that in the TbpA plug domain the
conserved EIEYE sequence is responsible for binding Fe3+. Previous studies by our lab (153)
have shown that in vivo that there is an 80% reduction in transferrin bound iron utilization in
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the triple alanine substituted TbpA plug, compared to the wildtype. This observation further
supports our hypothesis for this study.
The in-silico modeling data helped in creating a model for the wildtype and mutant
gonococcal TbpA plug domain. The EIEYE sequence is a long loop, with β-strands
anchoring the EIEYE motif. This loop could be flexible in nature due to the need for
coordination event occurring during the binding of Fe3+. The CD spectra and folding studies
showed that both the wildtype and mutated recombinant plug proteins did not show any
change in folding characteristics or stability properties in presence of Fe3+, this suggests that
the plug containing the EIEYE sequence must be a flexible loop, which allows for a fluid
reorganization during the ligand binding and transferring of Fe3+.
Upstream of the EIEYE sequence is another highly conserved region which showed
conformational differences between the wildtype and mutated TbpA plug structure. This
region is surface exposed, located at the apex of the molecule and called the top hat region
(figure 4). In the predicted models of the wildtype and mutated TbpA plug proteins, the
EIEYE-EIAAA mutation had the most drastic effect in the surface exposed top hat region. A
previous study from our lab worked with the triple alanine TbpA mutant, to look at the
ability of this triple mutant to grow on transferrin as the sole source of iron. The study
showed that the triple alanine mutant bound transferrin with wildtype affinity but showed
80% reduction in iron uptake and was unable to grow on transferrin, in a TbpB- background.
These data indicate that the EIEYE motif of the TbpA plug domain is important for
transferrin-iron internalization and plays an important role in iron acquisition.
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Figure 4: Schematic representation of the predicted structure of Neisseria gonorrhoeae wild
type TbpA plug domain. The highlighted EIEYE sequence is postulated to be important for
iron transport functions through TbpA. The red circle denotes the top hat region. Its importance
has been discussed in the test.
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This study is one of the first reports of the expression and isolation of the
recombinant wildtype TbpA plug. Our studies and results have provided information about
the iron coordination by the plug domain of TbpA in Neisseria gonorrhoeae. These results
pave the way for future studies to determine how the tightly-bound iron is released from
transferrin via the membrane-bound receptor complex, the importance of TbpA/TbpB in the
stripping of iron from transferrin, how iron is transferred to FbpA through the β-barrel
architecture and the role of TbpB in this process of transferrin mediated iron acquisition.
These studies will help us further our understanding to clarify the role(s) that each protein
plays in the multi-step transferrin-mediated iron transport mechanism in Neisseria
gonorrhoeae.
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CHAPTER 4: CONTRIBUTIONS OF TbpA DOMAINS, ENERGY AND LIGAND TO
INTERACTION BETWEEN GONOCOCCAL TRANSFERRIN BINDING PROTEINS

I.

INTRODUCTION
In the past, many studies have described indirect lines of evidence pointing towards the
formation of a gonococcal receptor complex between the transferrin binding proteins.
Gonococcal mutants expressing only TbpA showed reduced binding of transferrin, decreased
iron uptake from transferrin, but normal growth on transferrin plates. Mutants expressing
TbpB and not TbpA bound less transferrin, did not grow on transferrin plates, and did not
take up iron from transferrin (1). TbpB apparently facilitates binding of transferrin but is not
essential for acquisition of iron from transferrin; both the transferrin binding proteins need to
be expressed and work together to accomplish iron utilization from transferrin (1).
Protease accessibility assays showed that TbpA was more susceptible to proteolytic
attack in the absence of TbpB. TbpB can be efficiently cleaved by trypsin. All of the TbpB
expressed in the absence of TbpA was readily accessible to trypsin; however in the wild type
receptor there is some TbpB that is resistant to cleavage by trypsin (48). The presence of
TbpA partially protected TbpB from trypsin proteolysis, and TbpB also protected TbpA from
trypsin exposure. These observations indicate that TbpA and TbpB function together in the
wild-type strain, to evoke binding conformations that are distinct from those expressed by the
mutants lacking either protein. Protease accessibility experiments suggested that the
conformation or exposure of TbpB was dependent upon the presence of TbpA, consistent
with the hypothesis that the two proteins interact with each other (48).
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Like its meningococcal homolog (89), gonococcal Sarkosyl-solubilized TbpB could be
affinity purified (by transferrin) in the presence of TbpA, but not in absence of TbpA,
suggesting that TbpB might have bound to transferrin through TbpA under these conditions
(96). Alternatively, TbpB in the absence of TbpA may have adopted a different conformation
so that it no longer bound to transferrin in Sarkosyl. Under the same conditions, when TbpB
does not bind transferrin, affinity chromatography could help in the co-purification and
increase in the yield of TbpA-TbpB (96, 97). The altered properties shown by the proteins in
the affinity purification assay suggest that TbpA and TbpB appear to interact with one
another in wildtype gonococci.
Binding assays clearly depicted that the binding affinities of individual Tbps are different
from the intact receptor comprising of both of the Tbps (48). It was shown that the binding
characteristics of the wildtype receptor were described better using a two-site model. In
contrast, mutant gonococcal strains expressing only TbpA or mutant strain expressing only
TbpB exhibited binding affinities which were described by a single binding site model (48).
These results indicate that TbpA and TbpB when expressed independently in the mutants
bound transferrin with relatively high affinity in the liquid-phase binding experiments.
Analysis of the mutants indicated that neither protein expressed individually bound
transferrin with binding parameters that approximated those of the wild-type strain. This
suggested that the wild-type binding phenomena resulted from the combination of TbpA and
TbpB at the cell surface (48). This might allow us to say that TbpA and TbpB interact with
one another on the cell surface such that it leads to unique conformation and transferrin
interaction of the combined receptor complex.
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Studies with TbpA mutants in the TonB box of TbpA showed that these mutations had an
effect on the conformation of TbpB, implying that TbpA-TbpB interact on the gonococcal
cell surface (54, 158). To help define the individual roles of these receptors in the process of
transferrin-iron acquisition, the kinetics of the receptor proteins in regards to ligand
association and dissociation were evaluated. Both TbpA and TbpB demonstrated a two-phase
release pattern; however, TbpA required both TonB and TbpB for efficient transferrin
dissociation from the cell surface. Looking further into the roles of TbpA and TbpB in
transferrin dissociation it was proposed that TbpA and TbpB function synergistically during
the process of transferrin iron acquisition and that TbpB makes the process of transferrin-iron
acquisition more efficient at least in part by affecting association and dissociation of
transferrin from the cell surface (64).
All the above observations provide indirect evidence of interaction between TbpA and
TbpB. There are a number of different techniques to show direct interaction between
corresponding protein partners. In order to directly demonstrate an interaction event between
TbpA and TbpB we chose to utilize crosslinking assays. We used photo-activable
crosslinkers to probe the impact that TbpA has on the migration and conformation of TbpB.
Crosslinking reagents provide the means for capturing in-vivo protein-protein complexes
by covalently binding them together as they interact. The rapid action of the common
functional groups on crosslinkers allows even transient interactions to be frozen in place or
weakly interacting molecules to be seized in a complex stable enough for isolation and
characterization. Cross-linking experiments (in conjunction with immunoprecipitation) have
been utilized to identify major proteins of the gonococcal outer membrane that are
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responsible for imparting serotypic specificity (125), and yield information about the
antigenicity of surface-exposed, outer membrane gonococcal proteins (205, 206).
Sophisticated crosslinker designs have been created that incorporate photoreactive
groups, which react only in response to irradiation by UV light. We utilized L-photo-Leucine
and L-Photo-Methionine. These are photoreactive derivatives of amino acids and during
bacterial growth, proteins get metabolically labeled. Upon UV-irradiation, at specific time
points, the proteins get covalently crosslinked within protein-protein interaction domains in
their native environment in live cells. This method enables both stable and transient protein
interactions in cells to be studied and characterized without the use of completely foreign
chemical crosslinkers and associated reagent solvents during the interaction experiment that
can adversely aspects of the cell biology being studied. These photo-activable amino acids
have several advantages:


In vivo labeling of proteins using normal cellular machinery of metabolically
active cells.



In vivo crosslinking of interacting proteins in the native cellular environment.



Increased specificity as proteins correctly positioned at their interfaces within
protein interaction domains are crosslinked.



Efficient recovery after crosslinking.



Compatible and easy to use as they are photo-stable.

When used in combination with specially formulated limiting media that is devoid of
leucine and methionine, the photo-activable derivatives are treated like naturally
occurring amino acids by the protein synthesis machinery within the cell. As a result,
they can be substituted for leucine or methionine in the primary sequence of proteins
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during catabolism and growth. Photo-Leucine and Photo-Methionine derivatives contain
diazirine rings that activate when exposed to UV light to become reactive intermediates
that form covalent bonds with nearby protein side chains and backbones. Naturally
associating binding partners within the cell can be instantly trapped by photoactivation of
the diazirine-containing proteins in the cultured cells. Crosslinked protein complexes can
be detected by decreased mobility on SDS-PAGE followed by Western blot detection.
Based on earlier work, using computer predictions and similarity with other TonBdependent transporters, for which crystal structures have been determined, a hypothetical
model was proposed for gonococcal TbpA (20, 129). To investigate the surface-exposed
regions in TbpA, the Hemagglutinin (HA) epitope tag was inserted to create site-directed
mutants and the functional impacts of this mutagenesis were investigated. Of these
mutants, insertions into putative loops 2, 9, and 11 resulted in variants that bound
transferrin with wild-type affinity but could complete the iron acquisition process only in
the presence of a functional TbpB protein (20), which supports the contention that TbpA
and TbpB interact on the cell surface and could implicate putative loops 2, 9, and 11 as
contributors to a TbpA-TbpB interaction. Another TbpA mutant was created by targeting
the conserved motif in the plug domain. The triple alanine substitution mutant in TbpA
maintained wild type transferrin binding affinity (153). The mutant was unable to grow
on transferrin as a sole source of iron but TbpB expression compensated for this defect.
We are interested in investigating the characteristics of these mutants in terms of an
interaction between TbpA and TbpB, using photo-activable crosslinkers. Table 4 lists the
selected mutants to be studied, and Table 5 depicts the transferrin binding and growth
capabilities of these mutants.
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We hypothesize that TbpA and TbpB interact on the gonococcal cell surface. We
believe that certain residues of TbpA and TbpB are important for the interaction between
the two proteins. We would like to demonstrate the interaction between TbpA and TbpB
and assess the factors which play a role in the interactive abilities between these two
proteins, namely the presence of ligand and TonB derived energy.
This study will aid in better visualization of key structure-function relationships in the
gonococcal transferrin binding proteins. Knowledge about the transferrin receptor
complex, will give us a better understanding as to how these proteins function and the
characteristics of the receptor that are expressed in the bacteria.
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Table 4: HA-insertion mutants in TbpA selected for this study

Strains

Relevant characteristics

References

MCV515

L9HA(750) TbpA Lbp- (tbpA HA lbpB::Ω)

238

MCV519

L11HA(843) ΔAla847 TbpA Lbp- (tbpA HA lbpB::Ω)

238

MCV527

L2HA(229) TbpA Lbp- (tbpA HA lbpB::Ω)

238

MCV260

TbpAE120AY121AE122ATbpB+

153

MCV511

L3HA(343) TbpA Lbp− (tbpA∇HA lbpB::Ω)

238

MCV505

L5HA(509) TbpA Lbp− (tbpA∇HA lbpB::Ω)

238
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Table 5: Transferrin binding and growth capabilities of the selected site specific mutants in
transferrin receptor components.

Mutant

Transferrin binding
in presence of
TbpB

Growth on
transferrin in
presence of TbpB

Transferrin-iron
uptake in presence
of TbpB

MCV515

+

+

Not Determined

MCV519

+

+

Not Determined

MCV527

+

+

Not Determined

MCV260

+

+

+

MCV511

-

-

Not determined
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II.

RESULTS:
A. Identification of interaction between TbpA and TbpB

To study the effect of photo crosslinking on TbpA-TbpB interaction, gonococci
were grown with photo-activable cross-linkers under iron depleted conditions. Interacting
proteins, including the Tbps which are hypothesized to be situated extremely close to
each other on the gonococcal cell surface would then be cross-linked by UV exposure.
The shift or change in protein molecular mass was visualized by running protein samples
on SDS-PAGE gels and transferred to nitrocellulose membrane. TbpA was detected using
antibodies against TbpA and wild-type sized TbpB was detected by ligand-binding blot.
As an evidence of cross-linking of TbpA-TbpB, we measured the loss of full-length
TbpB. In the wild type strain we observed loss of TbpB under photo cross-linking
conditions (figure 5 and 6); however we didn’t detect specific higher molecular weight
(>200 kDa, cross-linked) protein complexes due to their inability to migrate through the
SDS-PAGE gel. In FA19 (the wild-type strain) photoactivation resulted in the formation
of multiple cross-linked protein species containing TbpA (seen in lane 2 of figure 5A)
and in the ligand binding blot it resulted in the loss of wild-type sized TbpB. We
measured loss of full-length TbpB as an indication of TbpA-TbpB interaction. The loss of
TbpB after photo crosslinking is shown graphically in figure 6. To check for specificity
in terms of a potential interaction between Tbps, we used a tbpA- mutant gonococcal
strain for analysis. In the tbpA mutant (FA6747), the wild-type TbpB protein was
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detectable to the same degree with and without photoactivation (figure 5B and figure 6),
indicating that the change in migration of TbpB was dependent upon the presence of
TbpA. Photo-crosslinking altered TbpB migration, only in the presence of TbpA.
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Figure 5: TbpA and TbpB detection in crosslinked samples of wildtype and TbpA mutant.
Gonococcal strains FA19 (wild type), and FA6747 (TbpA- mutant) were grown under irondepleted conditions in the presence of photo-activable cross-linkers. Cultures were UV irradiated
and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and transferred to
nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-HRP (B) to
detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed are labeled
as (-).

69

70

Figure 5: Quantification of TbpB in the wildtype and TbpA mutant. TbpB was detected by
ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type molecular
mass after cross-linking. Samples that are UV exposed are signified as UV (+) and that are nonUV exposed are noted as UV (-).
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B. Investigation of TbpA-TbpB interaction in HA-TbpA mutant
We tested selected HA insertion mutants (in the surface exposed loops of
TbpA), to investigate whether they were competent for interaction between TbpA
and TbpB. We selected loop mutants in positions L2, L3, L5, L9, L11 to be tested
for studying the effect of crosslinking on interaction between TbpA and TbpB.
Insertions into putative loops 2, 9, and 11 resulted in mutants that bound
transferrin with wild-type affinity but could complete the iron acquisition process
only in the presence of a functional TbpB protein (238). TbpB compensates for a
surface exposed mutation in TbpA; this implicates loops 2, 9, and 11 as
contributors to a TbpA-TbpB interaction. When we conducted ligand blot
analysis, the results showed that the TbpA-TbpB interactions between the wild
type strain and the loop 2 mutant (depicted in figures 7), loop 9 mutant (figures 9)
and the loop 11 mutants (figures 11), were similar. Graphical representation of %
of TbpB remaining after photo crosslinking gave similar results between the wild
type and loop 2 (figure 8), loop 9 (figure 10) and loop 11 (figure 12) mutants.
Previous deletion data indicated that L5 contains residues essential for
transferrin binding and utilization (20). The L5 HA-TbpA was unaffected in
ligand binding or transferrin-iron utilization. We chose to look at the TbpB
interaction abilities of the TbpA loop 5 HA mutant.
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Figure 7: TbpA and TbpB detection in crosslinked samples of wildtype and L2 HA-TbpA
mutant. Gonococcal strains FA19 (wild type), and MCV527 (L2 HA-TbpA mutant) were grown
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTfHRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed
are labeled as (-).
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Figure 8: Quantification of TbpB in the wildtype and L2 HA-TbpA mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).
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Figure 9: TbpA and TbpB detection in crosslinked samples of wildtype and L9 HA-TbpA
mutant. Gonococcal strains FA19 (wild type), and MCV515 (L9 HA-TbpA mutant) were grown
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTfHRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed
are labeled as (-).
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Figure 10: Quantification of TbpB in the wildtype and L9 HA-TbpA mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).
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Figure 11: TbpA and TbpB detection in crosslinked samples of wildtype and L11 HATbpA mutant. Gonococcal strains FA19 (wild type), and MCV519 (L11 HA-TbpA mutant)
were grown under iron-depleted conditions in the presence of photo-activable cross-linkers.
Cultures were UV irradiated and whole cell lysates were prepared. Proteins were separated by
SDS-PAGE and transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to
detect TbpA, and hTf-HRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+)
and non-UV exposed are labeled as (-).
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Figure 12: Quantification of TbpB in the wildtype and L11 HA-TbpA mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).
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Upon photo crosslinking, we observed that the L5 HA-TbpA mutant behaved in a
similar manner to the wild type strain, with the TbpB migration changed after UV
irradiation being similar between the wild type and the mutant (figures 12 and 13).
The L3HA mutant was not capable of transferrin binding; it was also unable to
mediate the transferrin-iron uptake process. That makes the mutant interesting to study,
since the inability to utilize transferrin-iron underlines the importance of this region. We
found that the migration of TbpB after crosslinking in the L3 HA-TbpA mutant was
similar to the wildtype (figures 15 and 16).
Previously in our lab, we created a TbpA triple alanine substitution mutant in a
conserved motif of TbpA plug, with the intention of finding residues in TbpA important
for iron utilization. This TbpA triple alanine mutant was defective in transferrin-iron
uptake and utilization (153). To test the capability of this mutated TbpA plug to interact
with wild type TbpB, we conducted photo crosslinking assays with this mutant. The
results showed similarity between the TbpB migration after photo crosslinking between
the wild type and the TbpA triple alanine mutant (figures 17 and 18).
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Figure 13: TbpA and TbpB detection in crosslinked samples of wildtype and L5 HA-TbpA
mutant. Gonococcal strains FA19 (wild type), and MCV505 (L5 HA-TbpA mutant) were grown
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTfHRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed
are labeled as (-).

87

88

Figure 14: Quantification of TbpB in the wildtype and L5 HA-TbpA mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).
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Figure 15: TbpA and TbpB detection in crosslinked samples of wildtype and L3 HA-TbpA
mutant. Gonococcal strains FA19 (wild type), and MCV511 (L3 HA-TbpA mutant) were grown
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTfHRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed
are labeled as (-).
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Figure 16: Quantification of TbpB in the wildtype and L3 HA-TbpA mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).
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Figure 17: TbpA and TbpB detection in crosslinked samples of wildtype and TbpA plug
mutant. Gonococcal strains FA19 (wild type), and MCV260 (TbpA plug mutant) were grown
under iron-depleted conditions in the presence of photo-activable cross-linkers. Cultures were
UV irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and
transferred to nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTfHRP (B) to detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed
are labeled as (-).
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Figure 18: Quantification of TbpB in the wildtype and TbpA plug mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).
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C. Effect of ligand addition on TbpA-TbpB interaction

To assess the effect of addition of ligand to the interaction between the Tbps, we added
30% iron-saturated human transferrin to our photo crosslinkers containing iron depleted
media and allowed for the wildtype gonococcal strain to grow in presence of ligand.
TbpA presence was detected by using polyclonal antibodies against TbpA. The banding
pattern in presence of ligand did not change much from what was observed without it.
The reduction of TbpB after photo crosslinking was similar for both the conditions
(figures 19 and 20). Binding of ligand does not alter the interaction between the Tbps in
the wildtype.

D. Effect of TonB derived energy on the TbpA-TbpB interaction

We next tested the TonB mutant, by growing the mutant gonococcal strain with photo
crosslinkers. We found that the TbpA immunoblots were similar between the wildtype
and the TonB mutant in terms of detecting TbpA under non crosslinked and crosslinked
conditions (figure 21-A). The amount of TbpB remaining after crosslinking is also
similar between the wildtype and the TonB mutant (figure 21-B and 22). This indicates
that there is interaction occurring between the Tbps, in the TonB mutant strain, implying
that the interaction was demonstrated in the absence of TonB derived energy.
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Figure 19: TbpA and TbpB detection in crosslinked samples of wildtype strain in absence
and presence of transferrin. Gonococcal strain FA19 (wild type) was grown under irondepleted conditions in the presence of photo-activable cross-linkers, with or without the addition
of human transferrin. Cultures were UV irradiated and whole cell lysates were prepared. Proteins
were separated by SDS-PAGE and transferred to nitrocellulose. Blots were probed with α-TbpA
serum (A) to detect TbpA, and hTf-HRP (B) to detect TbpB. Samples that were UV exposed are
labeled as (+) and non-UV exposed are labeled as (-).
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Figure 20: Quantification of TbpB in the wildtype strain in absence and presence of
transferrin. TbpB was detected by ligand-binding blot, and expressed as percent of TbpB that
remains at the wild-type molecular mass after cross-linking. Samples that are UV exposed are
signified as UV (+) and that are non-UV exposed are noted as UV(-).
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Figure 21: TbpA and TbpB detection in crosslinked samples of wildtype and TonB mutant.
Gonococcal strains FA19 (wild type), and MCV650 (TonB mutant) were grown under irondepleted conditions in the presence of photo-activable cross-linkers. Cultures were UV irradiated
and whole cell lysates were prepared. Proteins were separated by SDS-PAGE and transferred to
nitrocellulose. Blots were probed with α-TbpA serum (A) to detect TbpA, and hTf-HRP (B) to
detect TbpB. Samples that were UV exposed are labeled as (+) and non-UV exposed are labeled
as (-).
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Figure 22: Quantification of TbpB in the wildtype and TonB mutant strains. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the wild-type
molecular mass after cross-linking. Samples that are UV exposed are signified as UV (+) and
that are non-UV exposed are noted as UV(-).

106

107

When we added ligand (30% iron-saturated transferrin) to the TonB mutant strain
while growing with photo crosslinkers, we found that the amount of TbpB detected in the
TonB mutant, in crosslinked and non-crosslinked conditions remains the same (figures 23
and 24). This is in sharp contrast to what we observed for the wildtype strain where under
photo crosslinking condition there was loss of wildtype sized TbpB. The loss of TbpB
due to crosslinking indicates an interaction between TbpA-TbpB in the wildtype and the
above results indicate that in the TonB mutants addition of transferrin prevents the
interaction between TbpA-TbpB.
Overall the data suggests that photo-crosslinking altered TbpB migration, only in
the presence of TbpA. Upon addition of transferrin, we observed no significant difference
in the TbpA-TbpB interaction. The HA epitope insertions in TbpA do not seem to cause
disruption in TbpA-TbpB interaction. Binding of ligand does not alter the interaction
between the Tbps in the wildtype, similar to the result when a TonB mutant was used for
analysis, indicating that the TbpA-TbpB interaction is independent of TonB derived
energy. However in the de-energized system, addition of ligand prevented TbpA-TbpB
interaction.
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Figure 23: TbpA and TbpB detection in crosslinked samples of wildtype and TonB mutant
strains in presence of transferrin. Gonococcal TonB mutant strain was grown under irondepleted conditions in the presence of photo-activable cross-linkers, with addition of human
transferrin. Cultures were UV irradiated and whole cell lysates were prepared. Proteins were
separated by SDS-PAGE and transferred to nitrocellulose. Blots were probed with α-TbpA
serum (A) to detect TbpA, and hTf-HRP (B) to detect TbpB. Samples that were UV exposed are
labeled as (+) and non-UV exposed are labeled as (-).
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Figure 24: Quantification of TbpB in the wildtype and TonB mutant strains in presence of
transferrin. TbpB was detected by ligand-binding blot, and expressed as percent of TbpB that
remains at the wild-type molecular mass after cross-linking. Samples that are UV exposed are
signified as UV (+) and that are non-UV exposed are noted as UV(-).
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III.

DISCUSSION

Several studies aimed at elucidating the structural and functional characteristics of the
transferrin binding proteins have shown that the presence or absence of TbpA has a profound
effect on the functionality of TbpB. A TonB-box mutation in TbpA showed that the
energization state of TbpA had an effect on the protease accessibility of TbpB (48, 54).
These observations suggested that both Tbps are in close proximity of one another on the
cellular surface, and the TbpA energy-induced conformational change in TbpB could imply
that TbpA and TbpB interact on the gonococcal surface. Co-immunoprecipitation assays
conducted with the outer membrane fractions of gonococcal strains, led to the coimmunoprecipitation of TbpB using TbpA-specific antibodies (96). This suggests that there
is some population of TbpB that interacts with TbpA on the cell surface.
We hypothesized that the presence of TbpA impacts the exposure or conformation of
TbpB. In this study, we have utilized photoactivable cross-linkers to assess the effect of
TbpA on TbpB in live gonococcal cells and studied it in the presence of ligand and TonB
derived energy. We employed insertion mutants, in which TbpA contained the hemagglutinin
(HA) epitope tag, to probe for the impact of TbpA mutagenesis on TbpB. The crosslinking
approach has been successfully used before to study the interaction and recognition residues
between E. coli periplasmic protein partners, CusF and CusB (127). These two proteins are
part of the CusCFBA efflux system, which is involved in the metal extrusion from the
periplasm to the extracellular space. The structural details of the interactions
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between CusF and CusB were mapped through chemical cross-linking, coupled with highresolution mass spectrometry (127).
In our study, photo crosslinking experiments demonstrated that in the wildtype
gonococcal strain there was loss of wildtype size TbpB; this was absent in the TbpA mutant
strain. Our results demonstrate that photo-cross-linking altered TbpB size and migration and
was dependent on the presence of TbpA. HA epitope insertion mutants in surface exposed
loops of TbpA did not impact the mobility of cross-linked TbpB. It was demonstrated that
insertions into putative loops 2, 9, and 11 resulted in mutants that bound transferrin with
wild-type affinity but could complete the iron acquisition process only in the presence of a
functional TbpB protein (238). This suggests that TbpB can compensate for a mutation in
TbpA, resulting in a functional receptor. Because TbpB is exposed on the outer membrane,
the compensatory function of TbpB for overcoming the defect is bound to be on the cellular
surface. This implicates putative loops 2, 9, and 11 as contributors to a TbpA-TbpB
interaction. Our results indicate that the these loop 2, 9 ,11 mutants showed no hampering of
the TbpA-TbpB interaction. These loops might not contribute to the interaction between the
Tbps in the gonococci. The L3HA mutant was incapable of transferrin binding, (this mutant
was stuck at the first step of transferrin-iron utilization process), and it was unable to mediate
the iron uptake process, which is not surprising since the initial step of the process could not
be accomplished (238). This indicates that L3 region could be important for transferrin
binding and transferrin-iron acquisition process. This observation helped us choose the L3
HA mutant for analysis of the TbpA-TbpB interaction. Photo crosslinking experiments
showed that the TbpA-TbpB interaction was not affected in this mutant and indicates that L3
might not be involved in the TbpA-TbpB interaction. In the L5HA mutant the insertion
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region for the HA epitope tag was a variable region of TbpA. This mutant was unaffected in
ligand binding or transferrin-iron utilization, and as per our crosslinking analysis it was
unaffected in the TbpA-TbpB interaction. This might indicate that variable, surface-exposed
residues are not critical for the function of the receptor but may be important for immune
evasion and camouflage of the underlying conserved binding epitopes.
The triple alanine substitution mutants demonstrated decreased transferrin-iron
internalization and maintained the ability to utilize transferrin as a sole iron source, only in
the presence of TbpB (153), suggesting that for TbpB to compensate for TbpA mutation they
may have to interact for this process. However this mutant also demonstrated no disruption
of the TbpA-TbpB interaction in our study. This region of the plug might not play an
important role in the interaction between the Tbps; however the plug does bind iron during
the iron acquisition process (chapter 1).
Creation of a TonB mutant (54) allowed us to investigate the effect of energy status on
TbpA-TbpB interaction. Performing the crosslinking assay with the TonB mutants (both in
absence and presence of ligand) enabled us to make key observations with the TbpA-TbpB
interactions. In the TonB mutants, we observed that the de-energized state resulted in
wildtype TbpA and TbpB migration after cross-linking. Addition of ligand to the wild type
strain did not hamper the Tbps’ interaction. However the addition of human transferrin to the
de-energized mutant caused a change in TbpB migration after cross-linking. This result
indicates that when ligand is bound tightly and irreversibly to TbpA, the accessibility and
perhaps conformation of TbpB is altered.
In the TonB box mutants, TbpB seemed to show a difference in protease susceptibility
assays indicating an energy-induced conformational change in TbpB (54). This observation
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allowed the conclusion that the energization state of TbpA resulted in a conformational
change in TbpB, consistent with a physical interaction between the two outer membrane
proteins. It was speculated that the transient TbpA-TbpB interaction occurs only when TbpA
is energized. To illustrate our findings in context of the gonococcal transferrin mediated iron
acquisition system, we present two models (figure 25-A and 25-B) to put forth a possible
topology model for the difference in TbpB mobility and interaction with TbpA in a deenergized mutant. In presence of ligand, when TonB energizes TbpA, TbpA interacts with
TbpB, impacting its migration following crosslinking. When ligand is locked on TbpA
(occurs when TbpA is de-energized in a tonB mutant), TbpA cannot interact with TbpB. Our
in vivo studies suggest that in presence of ligand, de-energized TbpA does not interact with
TbpB.
Our conclusions from the crosslinking assays and its effects on TbpA-TbpB interactions
have been confirmed by the recent crystal structures of the homologous meningococcal
proteins (150, 151). These structural studies of TbpA-TbpB-ligand triple complex illustrate
that Tbps bind ligand through unique, non-over lapping binding sites such that TbpA and
TbpB do not interact. The X-ray, SAXS and EM structures support a consistent arrangement
for the TbpA–TbpB–(holo)hTF complex, where TbpA and TbpB bind through unique, nonoverlapping sites to assemble a triple complex. This assembled tri-complex encloses a
chamber at the union of the three protein components, and the TbpA and TbpB do not seem
to interact even though the walls of this chamber are comprised of TbpA-TbpB-hTf.
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Figure 25: Model of conformational change in the gonococcal transferrin binding proteins.
The gonococcal envelope consisting of outer membrane (OM), periplasm and inner membrane
(IM) is shown, along with the proteins constituting the transferrin mediated iron acquisition
pathway. Part (A) shows the model for conformation of the Tbps in energized state, after
crosslinking, and in part (B) the conformations during the de-energized conditions are shown. In
part (A), complex of TonB, ExbB, ExbD in the inner membrane transmits energy to TonBdependent TbpA. When TbpA is energized and ligand is present, then upon crosslinking, TbpA
interacts with TbpB and after iron extraction, apo-transferrin is recycled from the cell surface;
this affects the migration pattern of TbpB. When TbpA is de-energized (figure 21 part B), the
ligand gets locked onto TbpA, and this does not allow TbpA and TbpB to interact
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CHAPTER 5: CONTRIBUTION OF TbpB DOMAINS TO INTERACTION BETWEEN
GONOCOCCAL TRANSFERRIN BINDING PROTEINS

I.

INTRODUCTION
Pathogenic Gram-negative bacteria rely on the surface-exposed transferrin
receptor complex to acquire iron from host transferrin. TbpB, the second protein
component of the gonococcal transferrin receptor is a surface exposed lipoprotein.
TbpB is not required for iron internalization in the process of Tf-iron acquisition; it
makes the process more efficient. The exact mechanism by which efficiency is enhanced
is not known but a number of key studies have pointed out the importance of TbpB in
transferrin mediated iron acquisition process. TbpB increases the efficiency by its ability
to differentiate between apo- and holo-transferrin. Utilizing the relative transferrinbinding properties of both Tbps, it was showed that TbpB discriminated between ferrated
transferrin and apo-transferrin, while TbpA did not (48). In solid-phase binding assays
with isolated membranes, TbpA was shown to bind both apo and iron-loaded transferrin,
however TbpB discriminated between apo and holo transferrin. In binding assays with
TbpB and recombinant fusion proteins, it was observed that both intact TbpB and the Nterminal half of TbpB, preferentially bound iron-loaded transferrin (173). A mutant with
deletion of tbpB, but expressing wild-type levels of TbpA, showed reduced binding and
iron uptake from transferrin, but normal growth on transferrin plates. Mutants expressing
only TbpB bound less transferrin, and did not take up iron from transferrin nor did they
grow on transferrin plates. These results suggest that TbpB facilitates binding of
transferrin but is not essential for acquisition of iron from transferrin (1).
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To help understand the role of TbpB in transferrin iron utilization, a previous
study in our lab evaluated the kinetics of the receptor proteins with regards to ligand
association and dissociation (64). Transferrin association with TbpB was rapid as
compared to TbpA. TbpA required both TonB and TbpB for efficient transferrin
dissociation from the cell surface. It was proposed that TbpB makes the process of Tfiron acquisition more efficient at least in part by affecting association and dissociation of
transferrin from the cell surface (64). Using the SUPREX technique, for assessing the
thermodynamic stability of protein –ligand complexes, it was reported that TbpB
(individually or along with TbpA) can deferrate transferrin without energy supplied from
TonB resulting in sequestration by apo-FbpA (191).
Recently X-ray crystallography, small-angle X-ray scattering and electron
microscopy methods were used to look at the TbpB receptor from two N. meningitidis
strains in its apo form and in complex with human transferrin (31, 151). This analysis
was undertaken to elucidate how TbpA and TbpB function in binding human transferrin
selectively and extract its tightly bound iron at physiological pH. TbpB is a bilobed
protein; the two lobes are structurally similar. The N-terminal and C-terminal lobe are
each subdivided into a 8-stranded β-barrel domain and an adjacent β-rich handle domain.
The TbpB structures aligned closely with three TbpB structures from porcine pathogens
(32, 136) and N-lobe of TbpB showed the major sequence and conformational variations.
Residues affecting transferrin binding were situated on the distal surface of the N lobe
(32, 50, 136, 192) and confer much of the transferrin species specificity. TbpB primarily
binds the C lobe of human transferrin through its N lobe (151). It was also demonstrated
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that the major site of interaction lies in the N lobe. TbpB stabilizes holo-human
transferrin C-lobe by recruiting and sequestering holo- transferrin and maintains the ironloaded status of transferrin until its delivery to TbpA.
To look at regions important in TbpB for transferrin binding and transferrin-iron
uptake, HA epitope tagging was used. Nine insertion mutants were created, placing the
HA epitope downstream of the signal peptidase II cleavage site and the impact of each
insertion on the function of TbpB and the transferrin acquisition process was examined.
The results showed that both the TbpB lobes (N-terminal and C-terminal lobes) are
critical for efficient iron uptake from human transferrin (62, 150). These conclusions
were further strengthened by studies with TbpB from Neisseria meningitidis, which
showed that both N- and C-terminal domains together interact with human transferrin
(171). These findings point out one of TbpB’s contribution in the efficient binding of
TbpB to human transferrin and thereby increasing the efficiency of the transferrin-iron
acquisition pathway.
TbpB proteins are heterogeneous, with 69 to 84% sequence identity among
Neisseria gonorrhoeae strains and 64 to 75% identity when gonococcal TbpB proteins
are compared to those of Neisseria meningitidis (50). Regions of conservation have also
been demonstrated between TbpB proteins of N. gonorrhoeae, Actinobacillus
pleuropneumoniae, and Moraxella catarrhalis. Sequence analysis revealed conserved
regions interspersed within hypervariable domains of TbpB (172, 176). It is unclear as to
how or what portions of TbpB are involved in the protein's function.
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One conserved region in TbpB is the LSAC region, located at the N-terminal
domain of TbpB. This is a consensus sequence of lipoprotein modification/processing site
of Leu-(Ala, Ser)-(Gly, Ala)-Cys at -3 to +1 positions, representing the cleavage region
of 75% of lipoprotein signals in bacteria. Unmodified prolipoprotein with the consensus
sequence undergoes sequential modification and processing, the steps involved are: prior
to cleavage diacylglycerol group is transferred to the available sulfhydryl group of the
cysteine, after cleavage of the prolipoprotein the free amine group of cysteine is acylated
by N-acyl transferase to form mature lipoprotein (81, 235). The LSAC region located in
the N-terminus of TbpB, contains the signal II peptidase cleavage site. This signal
sequence is responsible for targeting TbpB through the inner membrane into the
periplasm. The LSAC lipobox with the cysteine residue serves as the first amino acid in
the mature lipoprotein and the site of lipidation.
Located just two amino acids downstream of the LSAC site is the second region
of interest, consisting of four glycine residues adjacent to each other. The importance of
this conserved poly-glycine stretch has still not been determined. This study aims to
determine the importance of the two, above mentioned conserved regions of TbpB (the
LSAC motif and the poly-glycine stretch), and the effect of mutations (in these two
regions) on the protein translocation, transferrin mediated iron utilization and TbpATbpB interactions. HA epitope insertions mutants in homologous regions in the Nterminal and C-terminal of TbpB were also used for investigating the interaction between
the transferrin binding proteins, thereby enabling us to study the importance of these
regions in the interaction between the transferrin binding proteins.
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II.

RESULTS
Using alanine substitution mutagenesis, in gonococcal TbpB, the prototypical
lipobox with the sequence LSAC was replaced with LAAA. The lipobox was replaced
with a consensus signal I peptidase cleavage site. This would allow the cleavage and
export of the lipoprotein but not the lipidation through the LSAC motif. The poly-glycine
region in TbpB was deleted to create a glycine deletion mutant (TbpB Δgly). Both of
these mutants were evaluated for lipidation and the translocation of the mature
lipoprotein through the cytoplasmic membrane. Figure 26 depicts a linear model of
TbpB, showing the LSAC and the glycine rich regions. This figure also shows the sites of
HA4 and HA8 insertions in TbpB.
A. LSAC mutation abolishes lipidation in TbpB and decreases the amount of
detectable, cell-associated TbpB

We determined the state of lipidation of TbpB. It was predicted that mutating
LSAC (lipidation site) could lead to absence of lipidation in the LSAC mutant. Lipidation
was prevented in the alanine substituted LSAC (LSAC-LAAA) mutant, whereas in the
Δglycine mutant the lipidation that was observed was similar to what was observed in the
wild type strain (figure 27, part A). These observations clearly point out that deletion of
the poly-glycine stretch (2 amino acids downstream of the LSAC site) had no effect on
lipidation, but the LSAC region is necessary for lipidation of TbpB.
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Figure 26: Linear model of TbpB: the model depicts the N-lobe and C-lobe of the
TbpB protein, with the LSAC site and the downstream glycine rich regions highlighted.
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Figure 27: Effect of the LSAC mutation on TbpB lipidation and cellular localization. (A)
Gonococci were grown under iron-depleted conditions in the presence of azide-labeled palmitic
acid. Bacteria were lysed and azide-labeled proteins were conjugated to biotin-alkyne. Following
separation by SDS-PAGE and transfer to nitrocellulose, proteins were probed with either antiTbpB antiserum or avidin-HRP. Control strains included FA19 (wild type) and FA6905 (TbpB−).
(B) Gonococci were grown under iron-deplete conditions and harvested by centrifugation. The
culture supernatant was treated with TCA to precipitate proteins. Following separation by SDSPAGE and transfer to nitrocellulose, membranes were probed using anti-TbpB antiserum. Lanes
labeled P contain proteins from the pelleted, whole cell fraction. Lanes labeled S contain proteins
from the supernatant fraction.
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With the absence of lipidation of the non-processed lipoprotein, it would seem
difficult for the protein to be anchored to the outer membrane, due to the absence of a
lipid moiety. To detect proteins released from the cell surface, TCA precipitation was
conducted with the cell-free culture supernatant. Presence or absence of TbpB was
investigated in the cellular pellet and the supernatant. In the wildtype strain most of
the TbpB was present in the cell pellet, with less TbpB detected in the supernatant.
The LSAC mutant showed some interesting results; majority of the TbpB was
detected in the soluble fraction of the supernatant, lesser quantities of TbpB being
detected in the cell pellet (figure 27, part B). This suggests that the absence of
lipidation had no effect on the transport of TbpB across the outer membrane, but led
to the absence of tethered-TbpB on the bacterial cell surface.
B. TbpB is surface accessible in the Δgly mutant but less so in the LSAC mutant
If the LSAC motif and the poly-glycine region played a role in the cellular
transport to the surface, it would play a role in the surface exposure of the TbpB. To
look at the surface accessibility of TbpB, protease accessibility assays were
performed. The LSAC mutant upon exposure to trypsin, showed an absence of
proteolytically digested (cell associated) products (figure 28). These results tell us
that in the lipobox mutant, TbpB is not presented on the cellular surface and absence
of cell-tethered TbpB peptides implies that the TbpB is not anchored to the
gonococcal cell surface. In the Δglycine mutant, trypsin addition gave rise to
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Figure 28: Surface exposure of TbpB. Bacteria were grown under iron depleted conditions
prior to exposure to trypsin. WCLs were prepared following 0, 15, or 30 minutes of trypsin
digestion. Undigested samples (U) were also included as a control. Proteins were separated by
SDS-PAGE, transferred to nitrocellulose, and probed with hTf-HRP. Strain FA19 was included
as a wild-type control.
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protease-digested, cell-associated, small peptide fragments; this observation was
similar to the wild type (figure 28), indicating that the TbpB was functional and
tethered to the outer membrane.

C. Impact of TbpB mutagenesis on transferrin-iron transporter function
To test transferrin-iron internalization by the LSAC and the Δglycine mutated
TbpB, double mutants were created by moving each of these mutations separately
into a TbpA L9HA background, and then testing these double mutants for growth on
transferrin as the sole source of iron. Gonococcal strain MCV515 is unique in the
sense that it is capable of growth on transferrin only when TbpB is expressed. The
insertion of HA epitope tag in the loop 9 of TbpA somehow disrupts epitopes in
TbpA such that iron internalization occurs only when wild type TbpB is present in the
strain. The MCV515 strain was able to grow on transferrin, the tbpB knockout strain
showed no growth; this was a similar trend in the TbpB LSAC mutant, which showed
no growth in presence of transferrin (figure 29). The TbpB Δglycine mutant showed
highly reduced growth, more easily deciphered at lower saturation levels of
transferrin (figure 29). These data inform us that the LSAC and the Δglycine
mutations in TbpB affect the iron-transferrin transporter function of TbpB.
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Figure 29: Effect of TbpB mutations on transferrin-iron utilization. Gonococci were plated
on CDM agarose plates containing human transferrin. Strains tested include (clockwise,
beginning at the top): (1) FA19 (WT), (2) FA6815 (A-B-), (3)MCV515 (L9HA), (4)MCV516
(L9HA, B-), (5) MCV858 (L9HA, LSAC), and (6) MCV860 (L9HA, Δgly)
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D. Mutations of the conserved amino-terminal regions of TbpB does not impair
interaction with TbpA
We utilized the cross-linking assay to evaluate the effects of LSAC and Δglycine
mutations on the TbpA-TbpB interaction. We incorporated photo-activable
methionine and leucine, into iron-depleted growth medium; and allowed the bacterial
strains to grow in presence of these cross-linkers. The cultures were UV exposed to
allow for cross-linking of interacting proteins, and then we identified full-length
TbpB using a ligand binding blot. As an evidence of cross-linking of TbpA-TbpB, we
measured the loss of full-length TbpB. In the wild type strain we observed loss of
TbpB under photo cross-linking conditions; however we didn’t detect any higher
molecular weight (cross-linked) protein complexes due to their inability to traverse
the SDS-PAGE gel. In the TbpA- strain, we observed that the intensity of TbpB being
detected was same both in non-cross-linked and cross-linked conditions, which
indicated to us that TbpA expression was important for the change in migration of
TbpB (figure 30). The LSAC and Δglycine mutants showed similar migration
patterns for TbpB, when compared to each other and the wildtype strain. When we
graphically measured the percentage of TbpB remaining after photo cross linking, we
observed that the decrease in TbpB in both the mutants was similar to the wild type
strain (figures 31 and 32). Even though the LSAC mutated TbpB was not anchored on
the outer membrane, it still possessed the capability of interacting with TbpA.
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Figure 30: TbpB detection in crosslinked samples of TbpB mutants. Gonococcal
strains FA19 (wild type), FA6747 (TbpA- mutant), MCV839 (LSAC mutant), and
MCV843 (Δgly mutant) were grown under iron-depleted conditions in the presence of
photo-activable cross-linkers. Cultures were UV irradiated and whole cell lysates were
prepared. Proteins were separated by SDS-PAGE and transferred to nitrocellulose. TbpB
was detected by probing the blots with HRP labeled Tf. Samples that were UV exposed
are labeled as (+) and non-UV exposed are labeled as (-).
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Figure 31: Quantification of TbpB in the wildtype and LSAC mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the
wild-type molecular mass after cross-linking. Samples that are UV exposed are signified
as UV (+) and that are non-UV exposed are noted as UV (-).
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Figure 32: Quantification of TbpB in the wildtype and Δgly mutant. TbpB was
detected by ligand-binding blot, and expressed as percent of TbpB that remains at the
wild-type molecular mass after cross-linking. Samples that are UV exposed are signified
as UV (+) and that are non-UV exposed are noted as UV (-).
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We also used the HA epitope insertion mutants in TbpB, in the cross-linking
assays. The TbpA and TbpB blots, with the non-crosslinked and crosslinked samples,
showed no difference between the wildtype strain and the HA4 mutant (part A and B in
figure 33). In contrast, the HA8 mutant showed no reduction of wild type sized TbpA and
TbpB (part A and B in figure 34) after crosslinking, unlike the wild type strain.
Findings from this section suggest that the lipid-tether deficient TbpB and
glycine-region deleted TbpB have not lost their capability of interacting with TbpA,
despite mutations in conserved regions of TbpB. We observed that the HA insertions in
positions 4 and 8 (depicted in figure 26) of TbpB protein, did not disrupt the interaction
between the transferrin binding proteins.

III.

DISCUSSION
Surface-exposed lipoproteins have been described in many Gram-negative bacteria, but

the signals and machinery involved in their localization remain to be characterized (112, 114,
159). In Neisseria, the cellular surface shows the presence of the lipoproteins (including
TbpB), which are tethered to the outer leaflet of the outer membrane by a lipid moiety (62).
Lipoproteins are also present in other gram-negative bacteria, like Klebsiella (145),
Bordetella (56), and E. coli (166); the mechanism for the transport of these lipoproteins
across the cellular membranes is largely unknown. In E. coli the lipoproteins are associated
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Figure 33: TbpB detection in crosslinked samples of TbpB mutants. Gonococcal
strains FA19 (wild type) and MCV814 (HA4-TbpB mutant) were grown under irondepleted conditions in the presence of photo-activable cross-linkers. Cultures were UV
irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE
and transferred to nitrocellulose. TbpA was detected by probing the blots with α-TbpA
serum (A) and TbpB was detected by probing the blots with α-TbpB serum (B). Samples
that were UV exposed are labeled as (+) and non-UV exposed are labeled as (-).
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Figure 34: TbpB detection in crosslinked samples of TbpB mutants. Gonococcal
strains FA19 (wild type) and MCV822 (HA8-TbpB mutant) were grown under irondepleted conditions in the presence of photo-activable cross-linkers. Cultures were UV
irradiated and whole cell lysates were prepared. Proteins were separated by SDS-PAGE
and transferred to nitrocellulose. TbpA was detected by probing the blots with α-TbpA
serum (A) and TbpB was detected by probing the blots with α-TbpB serum (B). Samples
that were UV exposed are labeled as (+) and non-UV exposed are labeled as (-).
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with the cell surface and majority of the E. coli lipoproteins are localized to the inner
leaflet of the outer membrane, on the periplasmic side (166). Many of these proteins are
transported through the inner membrane with the help of the general secretory pathway.
The Sec pathway that transports unfolded proteins into the periplasm consists of multiple
subunits. Proteins that are targeted to the Sec system have an N-terminal signal sequence,
with the lipoprotein signal II (lipoprotein peptidase cleavage site ) being unique due to
the cysteine residue. This signal sequence is responsible for targeting lipoproteins across
the inner membrane. Unmodified prolipoprotein is processed in a sequential manner to
form mature lipoprotein. (81, 235). The ABC transporter LolCDE binds these
lipoproteins in the inner membrane, releases them to LolA in the periplasm. LolA binds
at the lipid moiety of the protein, transports it through the periplasm and passes it onto to
LolB. LolB, situated at the periplasmic side of the outer membrane, incorporates the
lipoprotein into the outer membrane (210).
In the Gram-negative bacteria, the Lol system is well conserved (234). However,
Neisseria possesses only some of the Lol protein homologues. Since lipoproteins do
localize to the outer membrane in Neisseria, it is not known how the lipoproteins are
transported from the inner membrane to the outer membrane and then flipped over to the
outer leaflet of the outer membrane, unlike in E. coli.
In this study, we found that the TbpB mutant lacking the lipobox was released and
present extracellularly after transport across the outer membrane; with the non-lipidated
TbpB being retained less on the cellular surface. This indicates that the lipid moiety is
essential for TbpB to be tethered to the outer leaflet of the outer membrane and lipid
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modification was not necessary for transportation of TbpB into the extracellular matrix.
However, the LSAC motif (lipobox) of TbpB is necessary and sufficient for lipidation as
suggested by the palmitate labeling experiments. The cross-linking data showed the
presence of interaction between TbpA and mutated TbpB (from the LSAC mutant). The
presence of an interaction of TbpA with non-lipidated TbpB, suggests that this interaction
is not dependent on lipidation of TbpB and the small amount of mutated TbpB present on
the cellular surface or in the extracellular mileu, is still capable of interacting with TbpA,
by the virtue of its affinity for TbpA. The surface-exposure of TbpB was important since
lipid-modified TbpB, in the TbpA L9HA background, could not grow on transferrin as a
sole source of iron. In the transferrin mediated iron utilization the non-lipidated TbpB is
not able to assist TbpA for acquiring iron from transferrin; this could be due to its
reduced presence on the cellular surface or the non-tethering of the lipoprotein on the
outer membrane.
Though the poly-glycine stretch is only 4 amino-acids long, the deletion mutation
in this conserved region brought up some interesting findings. The protease accessibility
assay and solid-phase transferrin binding assay confirmed that the glycine deleted TbpB
remained surface exposed. The Δgly mutated TbpB was lipidated as confirmed by the
palmitate-labeling experiments. The TbpA-TbpB interaction was not affected by the
deletion of the poly glycine stretch in TbpB, however the same mutation when expressed
in the TbpA- background showed reduced growth in presence of transferrin. This
indicates that the mutated TbpB is deficient in transferrin-iron utilization. These findings
imply an important role of this poly-glycine region in TbpB and its function.
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This sort of glycine-rich domain is also found in surface exposed lipoprotein (also
a subtilisin-autotransporter) SphB1, in Bordetella pertussis. The N-terminal located
glycine-rich and proline-rich sequences facilitate the surface presentation of the
lipoproteins and the 14 residue long Glycine stretch is also hypothesized to be important
in targeting the lipoprotein to the outer membrane. Several other surface lipoproteins,
including Neisseria meningitidis TbpB and LbpB, hemoglobin (HpuA) receptor contain
Gly-rich motifs following the modified Cys residue that are reminiscent of the Gly-rich
stretch of SphB1(112, 114, 159). It is probable that such motifs are involved in the
surface presentation of these lipoproteins. Therefore, the short glycine-rich region could
function as an outer membrane localization signal, and may contribute to the surface
presentation and/or stability of gonococcal TbpB.

Data presented in a previous study indicated that both the N- and C-terminal
halves of gonococcal TbpB have the capacity to bind Tf, consistent with internal
sequence conservation of TbpB (62). The analysis identified internally homologous
regions within N- and C-terminal halves of TbpB. Homologous domains in N-terminal
and C-terminal halves of TbpB were targeted for HA insertion mutagenesis (figure 1).
The TbpB mutants with HA4 and HA8 insertions were similar with regard to surface
binding and iron internalization. Interruption of either region in TbpB reduced transferrin
binding and completely eliminated all known biological functions of gonococcal TbpB
(62). These mutants showed a dissimilar phenotype when they were analyzed through
crosslinking assays. The HA4 mutant showed similar interaction pattern to the wildtype
strain. It seems that the regions of TbpB, targeted for HA insertions, are less accessible
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and located within domains that could be partially hidden by other parts of the protein in
vivo. Therefore the insertion mutations did not disrupt the interaction between the
transferrin binding proteins. The HA8 TbpB mutant showed no diminishing of wild type
TbpA and TbpB being detected after crosslinking when compared to the crosslinked
condition and the wild type strain. This result indicates that in vivo the C-lobe of TbpB
may participate in interacting with TbpA and iron import. These results highlight the
critical contributions that each of these regions provides in the wild-type functions of
gonococcal TbpB.
Recent structural characterization of the neisserial iron import machinery has
helped refine our understanding of the manner in which TbpA and TbpB interact with
human transferrin during transferrin mediated iron acquisition. Human transferrin is a
bilobed glycoprotein (80 kDa) with each lobe consisting of two subdomains which form
the cleft: N1, N2, C1 and C2. Human transferrin interacts with TbpA and TbpB solely
through the C lobe. Whereas TbpA binds to both ferrated and deferrated forms of human
transferrin, TbpB has a strong preference for human transferrin with iron bound in the C
lobe (151). TbpB, which is tethered to the cell surface by an unstructured polypeptide
chain, is able to preferentially interact with iron-loaded human transferrin. TbpB
functions in selecting and capturing only those human transferrin entities, which are able
to provide iron on the cell surface of the bacteria. Recent X-ray, SAXS and EM structures
enabled in the study the TbpA-TbpB-(holo)hTf complex (150, 151). This triple complex
showed presence of an enclosed chamber, formed at the union of the three protein
partners such that TbpA and TbpB associate with different regions of the human
transferrin C lobe; to allow for iron transport (151). Therefore TbpB is important
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functionally to identify the iron-loaded and usable forms of human transferrin and to
efficiently sequester iron released from human transferrin and directionally transport it to
the TbpA barrel (through the formation of a potential iron chamber).

It has been shown in meningococcal TbpB, there is a presence of relatively
unstructured N-terminal anchor peptide (composed of amino acids 2-40), which is
associated with the C-terminal lobe of TbpB (236). It has been demonstrated that the
presence of the N-terminal anchor peptide region on TbpB is required for interacting with
TbpA in presence of transferrin. When the N-terminal lobe of TbpB binds transferrin, it
displaces the anchor peptide from its interaction with the C-terminal lobe. This brings
conformational changes in the anchor peptide, such that it moves the TbpB-Tf complex
closer on the outer membrane, so that it is able to interact with “activated” TbpA (bound
to TonB) (236). The anchor peptide region could extend TbpB sufficiently from the outer
membrane surface to facilitate capture of iron-loaded transferrin in the presence of
surface materials (193).

These observations when extrapolated to our study indicate that the poly glycine
region could function as an anchor region in gonococcal TbpB. The presence of the 4
glycine residues could be important in modulating the position of the TbpB (relative to
the outer membrane surface) and the formation of secondary structural features. These
secondary conformations could potentiate an interaction with TbpA. The glycine deletion
TbpB mutant was deficient in growth in presence of transferrin as a sole source of iron,
because the TbpB was impaired in its ability to interact with TbpA subsequent to human
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transferrin binding; thereby not allowing the iron internalization through the TbpA βbarrel conduit.
Through our study we have highlighted the functional importance of the two
conserved regions (LSAC motif and the poly-glycine region) of gonococcal TbpB. The
evidence presented here helps us to better understand the interactions occurring between
TbpA-TbpB-human transferrin. This data provides a deeper understanding of the
structural and functional aspects of two conserved regions in gonococcal TbpB.
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CHAPTER 6: SUMMARY AND PERSPECTIVES

Pathogenic bacteria, such as Neisseria, have specific outer membrane receptors
that bind to the host's glycoprotein transferrin. Transferrin is 80 kDa in molecular weight
and large enough that it cannot pass through the bacterial outer membrane. Therefore,
additional steps are required to remove iron from transferrin at the surface of the outer
membrane. Extraction of the iron from transferrin is brought about by TbpA-TbpB, the
two members of the transferrin-iron acquisition pathway. The mechanism of transferrin–
iron acquisition by N. gonorrhoeae has been the subject of a great deal of study. The
transferrin-iron acquisition system is composed of TbpA and TbpB protein members.
TbpA, the TonB-dependent transporter, is the essential member and the necessary portal
for iron travel through the outer membrane (52). TbpB, the surface-tethered lipoprotein,
is important for increased efficiency of the iron acquisition system (1, 62). The
gonococcal Tbp proteins are expected to interact through their interaction
domains/residues. The precise mechanism and nature of interaction between the
transferrin binding proteins is still poorly understood. The studies presented here helped
in understanding the interaction phenomenon between the transferrin binding proteins
and the importance of specific conserved regions in TbpA and TbpB in the overall
process of transferrin mediated iron acquisition.
The iron acquisition process in N. gonorrhoeae can conceptually be divided into
the following steps: recognition and binding of holo-transferrin at the TbpA/TbpB
surface; release of iron from transferrin and removal of apo-transferrin from TbpA
surface using TonB derived energy; passage of “free iron” through the β-barrel of TbpA;
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binding of the iron at the periplasm by FbpA (which is a part of an ABC transport
system); and finally the passage of iron to the cytosol with the help of FbpB and FbpC.
One of the aims of our study was to investigate the iron binding and extraction properties
of TbpA, specifically the conserved EIEYE motif in the TbpA plug domain. We also
investigated the interactions between TbpA and TbpB and study the importance of TonB
derived energy and ligand on these interactions. TbpB shares similarity with other
surface-exposed lipoproteins and the presence of an accessory lipoprotein is one of the
properties that makes the transferrin-iron acquisition system different from the
siderophore mediated iron acquisition. We studied the contribution of two conserved
regions in the TbpB protein (the LSAC and poly-glycine region) and their contribution to
interaction between the transferrin binding proteins.
Recently, the crystal structures of components of the meningococcal transferrin–
iron uptake system were reported (151, 189). The published reports indicate that TbpA is
one of the largest TonB-dependent transporters. TbpA consists of an N-terminal globular
plug domain loop that occluded the barrel pore and C-terminal β-barrel domain,
comprised of 22 β-strand transmembrane-spanning domains, with surface exposed loops.
Previous studies have suggested the importance of TbpA in transferrin utilization (238),
with the plug domain being critical for transferrin-iron acquisition and specifically
functioning in iron binding and uptake (154). Binding of Fe3+-siderophore complexes to
similar plug domains in outer membrane transporters during iron internalization has been
reported for E. coli receptors FepA and FhuA, which indicates an important role for these
plug domains in iron transport (69, 116, 215). Through sequence analysis it was shown
that in the plug domain of TbpA, sequence EIEYE (118–122) is highly conserved. In a
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triple-alanine substitution mutant of tbpA (EIAAA 118–122) there was an 80% reduction
in transferrin-bound iron utilization (although the mutant binds transferrin with wild type
affinity) (154). This shows the importance of the TbpA-plug sequence EIEYE in
transferrin-iron utilization by gonococci. We hypothesized that iron released from
transferrin at the TbpA surface interacts and binds with this plug sequence (EIEYE) and
is subsequently transported through the β-barrel of TbpA. Sequestration of Fe3+ by the
TbpA-plug supports the notion that the ferric iron must always remain chelated and
controlled throughout the transport process. Observations from the first part of this study
confirm that the EIEYE sequence in the wild-type TbpA plug binds Fe3+ during the outer
membrane transport process. This work has provided in-depth knowledge about
transferrin-iron internalization and is the first report of the expression/isolation of the
recombinant wild-type TbpA plug. The binding event between the sequence EIEYE and
Fe3+ is also supported by in silico modeling, depicting this sequence to be a part of a
flexible loop that can reorganize more easily. The models also predict another important
conserved sequence, which is surface exposed, as an important region for transferrin-iron
utilization and shows a considerable conformational change between the wild type and
recombinant plug. This ‘top hat’ region could act as a secondary recognition site for
transferrin interaction during iron internalization process, and this observation needs
further studies to be confirmed.

The gonococcal Tbp proteins are expected to work together during the transferriniron acquisition process, particularly in the presence of transferrin. The transferrin
binding proteins function together as a unit to acquire iron from transferrin but the nature
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in which they interact with transferrin is different for both of the proteins. In the second
part of this study we studied the interaction between the transferrin binding proteins by
utilizing crosslinking assays that included the use of photo crosslinkers. Our results
demonstrate that photo-crosslinking altered TbpB size and migration and was dependent
on the presence of TbpA. Previous studies using an HA epitope tagging approach had
been reported to probe the regions of TbpB and TbpA that are important for transferrin
binding and transferrin–iron uptake in gonococci (62, 123, 154). None of the HA epitope
insertion mutants in surface exposed loops of TbpA and TbpB deviated from the
interaction pattern that was seen in the wild type strain and the mutations did not impact
the mobility of cross-linked TbpB. The addition of transferrin to wildtype strain did not
change the interaction pattern of the transferrin binding proteins. Addition of transferrin
to the de-energized mutant caused a change in TbpB migration after cross-linking. This
result indicates that when ligand is bound tightly and irreversibly to TbpA, the surface
accessibility and perhaps conformation of TbpB is altered. Recent structural studies of
TbpA-TbpB-ligand triple complex (151) illustrate that transferrin binding proteins bind
ligand through unique, non-over lapping binding sites such that TbpA and TbpB do not
interact. Our in vivo studies suggest that in presence of ligand, de-energized TbpA does
not interact with TbpB. While the structures have significantly advanced our
understanding of the role of TbpA and TbpB in transferrin-iron acquisition pathway,
more studies are needed to fully elucidate the role of TbpB and its interactions with
TbpA.
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The last aim of the current study was to determine the contribution of two
conserved regions (the LSAC lipobox and the poly-glycine region), and the region with
the HA4 and HA8 epitope insertions within TbpB (figure 1) to the interactions between
the transferrin binding proteins. In a previous study, homologous domains in N-terminal
and C-terminal halves of TbpB were targeted for HA insertion mutagenesis (figure 1)
(62). The HA4 and HA8 TbpB insertion mutants were similar in surface binding and iron
internalization. Both of these mutants showed reduced transferrin binding and completely
eliminated all known biological functions of gonococcal TbpB (62). These mutants were
dissimilar in their interaction analysis through crosslinking assays. The HA4 mutant
showed similar interaction pattern to the wildtype strain, with no reduction in wildtype
sized TbpA and TbpB. It seems that the region of TbpB, targeted for HA4 insertion, is
located within a domain that could be partially hidden by other parts of the protein in vivo
and the insertion did not disrupt the interaction between the transferrin binding proteins.
The HA8 TbpB mutant showed no diminishing of wild type TbpA and TbpB being
detected after crosslinking when compared to the crosslinked condition and the wild type
strain. This result indicates that in vivo the C-lobe of TbpB may participate in interacting
with TbpA and subsequently iron import. These results highlight the critical contributions
that each of these regions provides in the wild-type functions of gonococcal TbpB.
We demonstrated that the lipobox, but not the glycine-rich domain, is required for
lipidation of TbpB and tethering to the outer membrane. These results indicate that TbpB
transport is lipoprotein-specific mechanism. When these mutant TbpB proteins were
expressed in a strain simultaneously expressing a mutant form of TbpA that requires
TbpB for iron acquisition, growth on transferrin was either completely abrogated or
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dramatically diminished. We conclude that surface localization of TbpB is required for
optimal performance of the transferrin-iron acquisition system, while the presence of the
poly-glycine stretch near the amino-terminus of TbpB contributes significantly to the
function of the transporter. These results provide important insights into the functional
roles of two conserved regions of TbpB, furthering our understanding of this critical iron
uptake system. Furthermore these observations may be broadly applied to other lipidmodified receptor proteins of the pathogenic Neisseria.
In search of a cross-protective gonococcal vaccine, focus is on receptors that are
necessary for nutrient acquisition. One such nutrient is iron. Iron acquisition is critical for
the bacterial survival in vivo and in tissue culture systems, and bacterial components
involved in the iron acquisition process could represent conserved targets for vaccine
development. Members of the transferrin-iron acquisition pathway, TbpA and TbpB are
prospective vaccine candidates because TbpA and TbpB are not subject to high frequency
phase or antigenic variation like other virulence factors of Neisseria gonorrhoeae, they
are expressed by all gonococcal isolates (132), and they are required for initiation of
infection in human male volunteers (53). The transferrin binding proteins of Neisseria
gonorrhoeae and Neisseria meningitidis are similar in sequence (1, 47), suggesting that a
vaccine comprised of these antigens could potentially protect against both gonococcal
and meningococcal infections. In Neisseria meningitidis it has been shown that antibodies
against transferrin binding proteins are bactericidal, cross-reactive and block the binding
of transferrin (59, 177, 229). In Neisseria gonorrhoeae antibodies against recombinant
gonococcal transferrin binding proteins are bactericidal and cross-reactive (164, 165).
These observations highlight the potential that the transferrin binding proteins possess to
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be developed as vaccine candidates. Identification of novel and important targets in TbpA
and TbpB will aid in the development of vaccines against Neisseria infection.
Our results presented here, help in elucidating the involvement of both the
transferrin binding proteins in the transferrin mediated iron acquisition pathway. With
this knowledge we have gained more in-depth understanding of the requirements for a
functional interaction between gonococcal TbpA and TbpB. By looking at the structural
and functional properties of the gonococcal transferrin receptor, we have a better
understanding of mechanisms by which the gonococcus acquires iron from human
transferrin. Knowledge about the transferrin receptor proteins will give us a better
understanding as to how these proteins function and the characteristics of the receptor
that are expressed in the bacteria. This knowledge is essential for the rational design of a
vaccine comprised of one or both of the transferrin binding proteins. Information derived
about this receptor may be extended to other transferrin receptors such as those expressed
in N. meningitidis, Moraxella catarrhalis, and Haemophilus influenzae.
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